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Estrogen toxicity has been an area of priority in aquatic toxicology over the last 20 
years. The toxicity of a known estrogen mimic, 17α-ethinylestradiol (EE2), has been 
attributed to classical estrogen signaling within target and non-target organisms. Recent 
evidence has indicated that a rapid, non-genomic, non-classical estrogen signaling pathway 
also exists via the G protein coupled estrogen receptor (GPER). GPER is expressed 
ubiquitously and has many biological functions, including cardiovascular and metabolic 
function. Understanding the role of GPER at environmentally relevant concentrations of 
estrogens could aid addressing many knowledge gaps associated with estrogen toxicity in 
aquatic environments.  
This thesis investigated the effects of EE2 on heart rate and metabolism, as well as 
EE2 uptake, and elimination in embryonic Japanese medaka (Oryzias latipes). Bradycardia 
(reduced heart rate) was observed in embryos exposed to 10 ng/L of EE2. It was 
demonstrated that these effects were the result of GPER activation and not estrogen 
receptor (ER) α and β. A mixture of EE2 and hydroxypropyl-β-cyclodextrin (HPβCD) was 
also investigated. HPβCD is a commonly used odour suppressant and excipient with the 
ability to include guest compounds. It was determined that the observed EE2 induced 
bradycardia was reduced with a 4:1 HPβCD : EE2 molar ratio. Uptake of 14C-EE2 followed 
a sigmoidal pattern, and chorion permeability increased as development progressed. 
Elimination of 14C-EE2, showed a pattern of exponential decay following exposure from 
6-48 hours post fertilization. HPβCD did not impede uptake of 14C-EE2 across the chorion, 
suggesting that HPβCD may cross the chorion. Uptake of the HPβCD – EE2 mixture into 
the tissues of the developing embryo should be investigated. A conclusive link was not 
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determined between EE2 induced bradycardia and embryonic oxygen consumption 
(metabolic rate). The absence of metabolic effects might be mitigated by cutaneous gas 
exchange by embryonic fish. This data suggests that embryonic heart rate may not be an 
ideal measure of metabolic rate in embryonic medaka. 
This thesis is valuable to the field of aquatic toxicology as it highlights GPER as a 
novel mechanism of action for EE2 toxicity as well as the role of HPβCD in mixture 
toxicity. This work and future research into the role of GPER will aid in the overall 
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1. Chapter 1: Literature Review 
1.1. Introduction 
Over the last 20 years, there has been heightened environmental awareness 
regarding the release of pharmaceuticals and personal care products (PPCPs) into the 
aquatic environment. Pharmaceuticals are a diverse group of biologically active medicinal 
compounds used to treat disease in both humans and livestock (Corcoran et al., 2010), 
whereas personal care products such soaps, detergents, and deodourizers are used on a 
daily basis for personal hygiene. High levels of consumption has resulted in the detection 
of PPCPs in surface waters in the ng/L to µg/L range. PPCPs at these concentrations have 
been shown to have the ability to elicit affects in non-target organisms (Overturf et al., 
2015). 
Steroid hormones are among the most commonly studied pharmaceuticals in 
environmental toxicology. These pharmaceuticals are very important due to their ability to 
elicit toxicological responses to non-target organisms (Parrott and Blunt, 2005; Kidd et al., 
2007; Overturf et al., 2015). Synthetic steroids in human contraceptives are of particular 
interest because of their frequency of prescription, presence in the environment, and their 
ability to cause physiological impacts in non-target organisms at environmentally relevant 
concentrations (Parrott and Blunt, 2005; Kidd et al., 2007; Santos et al., 2014). The most 
heavily studied synthetic steroid in the field of environmental toxicology is 17α-
ethinylestradiol (EE2). Many studies have shown that EE2 can cause reproductive 
impairment in fish at concentrations in the low ng/L range (Parrott and Blunt, 2005; Kidd 
et al., 2007; Overturf et al., 2015). The focus of much of this research has been centered 
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on the effects of EE2 activating nuclear estrogen receptors in fish. These receptors are 
ligand-dependent transcription factors, and when activated often result in modulation of 
gene expression. Changes in gene expression from EE2 exposure have been shown to alter 
protein production, contributing to the feminization and reproductive impairment in fish 
(Parrott and Blunt, 2005; Kidd et al., 2007). 
Currently, there is a significant knowledge gap in the role of G protein-coupled 
estrogen receptor (GPER), formerly known as GPR30, in EE2 toxicity (Diamante et al., 
2017). Activation of this receptor is typically thought to result in a more rapid physiological 
response since it is not a ligand-dependent transcription factor (Diamante et al., 2017; 
Romano et al., 2017). Recent research has suggested that embryonic heart rate can be 
utilized as an important physiological biomarker to assess GPER activity in fish (Romano 
et al., 2017). The impacts of EE2 on fish embryonic heart rates in and metabolism at 
environmentally relevant concentrations have not been studied in detail. One objective of 
this thesis is therefore to assess the effects of EE2 on heart rate and embryonic metabolism 
in relation to GPER using embryonic Japanese medaka (Oryzias latipes). 
Another interesting group of PPCPs is deodourizers, specifically cyclodextrins. 
Cyclodextrins are commonly used in both the personal care and pharmaceutical industry 
as deodourizers and as excipients, respectively. This is done through the inclusion of guest 
compounds within the cavity of the cyclodextrin molecule (Del Valle, 2004). Inclusion of 
guest compounds often results in improved solubility and altered bioavailability. In the 
field of environmental toxicology, the potential for cyclodextrins to alter the toxicity of the 
compounds that they include has been understudied. Unfortunately, effluent and surface 
water concentrations of cyclodextrins are unknown, highlighting a future area of research. 
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However, understanding the effects of toxicants in the presence of cyclodextrins is an 
important step in characterizing whole-effluent toxicity to non-target organisms. Another 
objective of this thesis is thus to determine the effects of cyclodextrins on EE2 toxicity. 
1.2. Aquatic Toxicology 
Aquatic toxicology is the study of the toxicity of contaminant substances on aquatic 
organisms, of which fish are often utilized due to their economic importance, and their 
continuous surface water exposure via effluent and run-off.  
There are two major classes of toxicity, acute and chronic. Acute toxicity is defined 
as a stimulus that is severe enough to cause a response within a short period of time, 
typically 96 hours for fish (Sprague, 1969). Chronic toxicity is a measure of a biological 
response to a stimulus over a prolonged period. A chronic exposure is usually defined as 
lasting greater than one tenth of an organism’s life cycle (Sprague, 1969). 
The majority of compounds studied in a laboratory setting are tested individually. 
While this approach is crucial for understanding individual modes of action and effect 
concentrations, it does not represent real world exposures in which organisms encounter 
multiple chemicals simultaneously. 
1.2.1. Mixture Toxicity 
Toxicity studies of mixture contaminants have become increasingly more frequent. 
Mixture toxicity is important when assessing the effects of effluents or surface waters that 
contain more than one potential toxicant. In brief, there are three major toxicological 
outcomes when toxicants are mixed: antagonism, synergism, or no interaction (Sprague, 
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1970). If two or more toxicants mixed together result in a reduction in toxicity, this is 
known as antagonism (Sprague, 1970). Synergism occurs when the mixture toxicity is 
additive, more than additive (potentiation), or less than additive (Sprague, 1970). Mixture 
toxicity is inherently more complexed than individual compound toxicity, but it is an 
important area of research as it better represents real world conditions. 
1.2.2. Embryonic Toxicity Testing  
The use of fish embryos in aquatic toxicology studies has increased in recent years. 
There has been a substantial movement in animal ethics and testing to adhere to the three 
R’s principle (replacement, reduction, and refinement), when utilizing animals for research 
(Braunbeck et al., 2015). Additionally, the pressure to increase throughput while reducing 
experimental costs has been problematic in many experimental laboratories. The use of 
embryonic fish in aquatic toxicological studies is one approach to help alleviate this issue.  
Embryonic fish are thought to be far less sentient than juvenile or adult fish. Thus, 
in most animal ethics regulations, embryo fish are not included as ‘animals’ which provides 
for the replacement portion of the three R’s. Additionally, the number of adults or juvenile 
fish required for testing is reduced through the use of embryos. Embryonic testing can 
allow for greater refinement of concentration ranges or aid in identifying lethal compounds 
without having to expose juvenile or adult fish to these levels of toxicants. Embryonic 
toxicity testing can also improve throughput while reducing associated costs. For example, 
the volume of exposure solution is dramatically lower, often 1000-fold, when exposing 
embryos compared to adults, saving on chemical costs, waste management as well as 
laboratory space. Embryonic testing retains the benefit of being able to test toxicity during 
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the major stages of development including organogenesis. This may allow for a better 
understanding of the mode of action of a particular toxicant. Finally, embryonic 
development of warm water fish is often relatively quick, between 4 and 10 days post 
fertilization, which coupled with the reduced volumes required, aids in the throughput of 
testing.  
Embryonic testing does have some limitations. Firstly, the chorion surrounding the 
embryo has the potential to block the uptake of some toxicants (González-Doncel et al., 
2004; Braunbeck et al., 2005). Generally, toxicants that are hydrophilic or bulky in size 
have more difficulty crossing the chorion (Braunbeck et al., 2005). This could potentially 
result in no-effect-concentrations (NOECs) in embryos that would otherwise result in 
toxicity to juveniles or adults. On the other hand, embryonic fish have a very high surface 
area to volume ratio, potentially increasing the relative uptake of toxicants that are able to 
readily cross the chorion. Researchers must thus be aware of the chemical nature of the 
toxicant(s) being used. Furthermore, organismal development is often not completed 
during embryogenesis and hatching. Many embryonic physiological processes may thus 
not be fully functional compared to adults and juveniles, which can impact embryonic 
susceptibility to a particular toxicant. For example, a toxicant that must be bio-transformed 
to elicit a toxic response may be perceived as non-toxic in an embryo that does not yet have 
the capabilities to conjugate toxicants. 
The Organization for Economic Co-operation and Development (OECD) has 
created guidelines for toxicant testing using aquatic organisms. Recently Test No. 236, Fish 
Embryo Acute Toxicity Test (FET) was developed (Braunbeck et al., 2015). This test was 
developed to utilize zebrafish (Danio rerio) over 96 hours. A strong correlation between 
6 
 
the FET and traditional acute toxicity tests was shown, suggesting that FET is useful for 
assessing acute toxicity at later life stages (Braunbeck et al., 2015).   
1.3. Test Species 
1.3.1. Teleost Fish as Research Organisms 
Fish are among the most commonly used research organisms when assessing 
aquatic toxicity. This is partly due to their high economic, intrinsic, and ecological value 
in Canada and globally. Fish also inhabit surface waters, which are a major receiving 
environments for many pollutants as they are washed down drains or run off of the 
landscape (Figure 1). 
Teleost fish are specifically seen as important research organisms in the field of 
aquatic toxicology due to the proportion of species they represent globally. They are the 
largest infraclass in the class Actinopterygii, and represent 96 % of all extant species of 
fish (~26000 species), and 40 % of all vertebrate species globally. 
Teleost fish are particularly valuable when assessing the toxicity of 
pharmaceuticals because they exhibit a high level of biological conservation for many 
human drug targets. In one study using 10 species of fish, including Japanese medaka, fish 
showed a high level of conservation in 81-86 % of the of 459 human drug targets examined 
(Brown et al., 2014). Additionally, a strong conservation in six nuclear steroid receptor 
ligand binding domains was also observed (Brown et al., 2014). The global representation 
of teleost fish coupled with the likelihood of exposure and potential susceptibility to 
environmental contaminants make fish valuable research organisms. 
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1.3.2. Japanese Medaka (Oryzias latipes) 
The teleost species of fish used in this thesis was the Japanese medaka (Oryzias 
latipes), which are native to freshwaters in China, Korea, and Japan. Medaka can reach 
sexual maturity in approximately 2 months with a maximal size of 2.5 – 3 cm and exhibit 
sexually dimorphic dorsal fins at maturity (Shima and Mitani, 2004). Medaka are 
oviparous, dawn spawners, and fertilize externally, often producing 10-30 eggs per female 
per day (Iwamatsu, 2004). These factors and their ease of maintenance have made medaka 
excellent experimental organisms. Medaka embryos have a clear chorion, allowing for 
direct observation of the embryonic stages of development (Iwamatsu, 2004; Shima and 
Mitani, 2004). Consequently, medaka have been used extensively in reproductive and 
embryo toxicity studies. 
Wild type medaka have leucophores that emit auto-fluorescence when observed 
under a fluorescence microscope (Shima and Mitani, 2004). However, many different 
strains of the Japanese medaka exist, including the female leucophore-free (FLFII) strain. 
FLFII medaka utilized in this thesis were obtained from the National Institute for Basic 
Biology (Okazaki, Japan) and cultured in-house. FLFII females do not produce leucophore 
cells, while males remain as wild type (Balch et al., 2004). This strain thus allows gender 
differentiation as early as 72 hours post fertilization in FLFII medaka. This is important for 
assessing gender differences in toxicity during embryogenesis which is often not possible 
using other species of fish. Importantly, no differences in E2 sensitivity were observed 
between FLFII and wild type medaka gonadal phenotypes (Balch et al., 2004). 
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1.4. Teleost Physiology 
1.4.1. Embryogenesis 
The embryonic phase of a fish is defined as the period of time after fertilization and 
before hatching. The embryo is encapsulated within an envelope known as the chorion and 
remains dependent on the yolk for nutrients. Embryonic development, or embryogenesis 
of fish can be broken down into 6 broad periods: fertilization, cleavage, germ layer 
formation, axis formation, neurulation, and somite development. The following paragraphs 
briefly outline some of the 39 stages of normal embryonic Japanese medaka development 
as described by Iwamatsu (2004). 
Stage 0 of medaka development consists of an unfertilized mature egg, they are 
spherical with an average diameter of 1200 µm. Unfertilized eggs contain yolk within the 
chorion and attachment fibers on the exterior surface. Stage 1 is initiated when an egg is 
stimulated by the sperm of a male medaka. This occurs externally and initiates a wave of 
exocytosis, the chorion then hardens. Male and female pronuclei fuse together forming the 
zygote nucleus, concluding stage 2. 
Cleavage begins to take place at approximately 1 hour post fertilization and is 
classified by the division into 2 cells. The cells continue to cleave in stages 2 to 8, during 
this phase the number of cells doubles with each cleavage and the volume of each cell 
halves. The embryo then will begin to enter germ layer formation. 
Germ layer formation is characterized by the formation of the endoderm, 
mesoderm, and the ectoderm. In medaka this occurs at approximately 4 hours post 
fertilization the embryo during stages 8 to 16, the morula, blastula, and gastrula stage. 
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During these stages blastodermal cells begin to grow flattened to the curvature of the yolk 
until it is nearly enveloped. 
At 25 hours post fertilization the embryo enters the neurula stage, stages 18 and 19. 
The head of the medaka begins to form followed by the brain, nerve cord, and optic bud. 
This leads into the somite stage of development. 
The somite stage is defined as the division of the embryo into defined segments and 
begins at 27.5 hours post fertilization. The eyes and auditory vesicles begin to form, and at 
38 hours post fertilization the tubular heart becomes present underneath the head (stage 
22). The heart begins to beat at stage 24, 44 hours post fertilization, and pulsation of the 
heart extends to the forebrain. Circulation begins at 50 hours post fertilization with a heart 
rate between 70 and 80 beats per minute. During stage 28, 64 hours post fertilization the 
bulge of the liver becomes definitive. In the heart, the sinus venosus, atrium, ventricle and 
bulbous arteriosus differentiated in stage 29, 74 hours poster fertilization. The gills and 
brain become visible, and the hepatic vein is functional at 82 hours post fertilization. Stage 
36 known as the heart development stage is initiated at 144 hour post fertilization. The 
atrium and ventricle lie adjacent to one another in the lateral view. At 168 hours post 
fertilization the pericardial cavity visibly surrounds the heart. Finally, at stage 39, at 216 
hours post fertilization, the embryo begins to hatch. Medaka embryos hatch by dissolving 
the inner chorion and escape tail first (Iwamatsu, 2004). 
1.4.2. The Chorion 
The chorion, is an acellular envelope that separates ovulating eggs and developing 
embryos from the surrounding environment (Hart, 1983). The major functions of the 
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chorion are to aid in fertilization, gas exchange, attachment to substrates in demersal eggs, 
as well as protection from microorganisms, physical harm from toxins or toxicants 
(Schoots, 1982). Most teleost fish possess a multi-layered chorion. The outer surface is 
commonly coated in filaments which aid in attachment to other eggs or substrates (Schoots, 
1982; Iwamatsu, 2004). A primary envelope is often located below the outer surface. 
Depending on the species, a secondary or tertiary envelope may also exist. 
1.4.2.1. Chorion Permeability 
A major assumption when testing the toxicity of a substance is that the chemical in 
question is able to interact with the test organism. This can be problematic when assessing 
embryonic toxicity. As with many biological membranes, bulky or hydrophobic 
compounds have difficulty crossing the chorion while water, electrolytes, and small 
lipophilic compounds cross the chorion relatively freely (Braunbeck et al., 2005). The 
layers of the chorion are spanned by toroidal shaped pore canals that have been shown to 
restrict entry based on the size and charge of the molecule (Kais et al., 2013). Zebrafish 
pore canals have been known to exclude compounds greater than 3-4 kDa (Souder and 
Gorelick, 2017). The permeability of compounds often varies across embryogenesis and 
species (González-Doncel et al., 2004). 
After fertilization, and in the presence of water, the chorion begins to undergo 
hardening. Chorion hardening is characterized by a dramatic increase in the rigidity of the 
membrane caused by a change in the protein composition. During this stage, the 
permeability of the chorion often decreases; as the embryo develops, permeability often 
increases over time (Adams et al., 2005). In carp (Cyprinus carpio), as development 
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progresses, pore diameter increases, often improving permeability (Rubstov, 1981). 
Japanese medaka embryos begin to degrade their chorion at stage 34, approximately 120 
hours post fertilization, increasing chemical permeability (González-Doncel et al., 2004). 
1.4.3. Teleost Cardiovascular System 
The cardiovascular system of fish is similar to most vertebrates in that it is a closed 
system that is responsible for delivering blood to tissues for gas and nutrient exchange. 
Teleost fish have a single circuit cardiovascular system that is pressurized by the pumping 
of a three chambered heart consisting of the sinus venosus, atrium and ventricle (Evans et 
al., 2013). Deoxygenated blood enters the heart through the sinus venosus, which acts as a 
thin walled reservoir. From there, the blood travels to the thicker walled atrium which can 
expand greatly when filled with blood. As the atrium contracts, the atrioventricular valve 
opens allowing blood to flow into the relaxed ventricle (Evans et al., 2013). The ventricle 
is thick walled and its contraction is responsible for producing the bulk of the blood 
pressure in fish. Blood exits the heart through the outflow tract. The outflow tract is an 
elastic structure that mediates the connection between the ventricle and ventral aorta by 
absorbing some of the high pressure released from the ventricle (Evans et al., 2013). Blood 
then enters the gills where it is oxygenated through a counter current mechanism of gas 
exchange before traveling to the rest of the body. After gas and nutrient exchange in the 




1.4.3.1. Teleost Heart Rate 
Cardiac control systems adjust heart rate in response to changes in respiratory 
demands, or metabolic rate (Vornanen, 2016). In most teleost fish, cardiac control acts on 
pacemaker cells located in specialized tissue at the junction of the sinus venosus and atrium 
(Evans et al., 2013; Vornanen, 2016). Pacemaker cells control the rate of cardiac myocyte 
contraction through the initiation of action potentials in vertebrates (Vornanen, 2016). 
Cardiac myocytes located in the atrium and ventricle start and finish an action potential at 
a stable negative resting membrane potential, usually between -70 and – 90 mV (Vornanen, 
2016). An action potential in the cardiac myocyte is initiated by an action potential from 
pacemaker cells; this causes the rapid depolarization of the membrane to +10 to +40 mV 
(Vornanen, 2016). This change is the result of the opening of sodium channels allowing 
for the influx of Na+ ions. Once at the peak of the action potential, repolarization is initiated 
by the opening of potassium channels. This results in the efflux of K+ ion from the cardiac 
myocytes causing the membrane potential to become more negative (Vornanen, 2016). 
However, a simultaneous influx of Ca2+ ions during this phase delays the repolarization 
causing a prolonged positive plateau in the action potential, especially in ventricular 
myocytes (Vornanen, 2016). This calcium induced plateau is essential to prevent cardiac 
muscles from contracting prematurely (Vornanen, 2016). The plateau also extends the 
contraction of ventricular myocytes allowing for the ejection of blood to take place 
(Vornanen, 2016). 
Pacemaker action potentials differ from atrium and ventricle action potentials in 
that they do not have a stable resting membrane potential. The resting membrane potential 
of pacemaker cells is usually between – 50 and -65 mV and they experience creeping 
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membrane depolarization (Vornanen, 2016). This creeping membrane depolarization 
results in a regular firing of the pacemaker action potential at the threshold potential 
(Vornanen, 2016). The plateau phase of pacemaker action potentials is not as prominent as 
in the ventricular and atrial myocytes due to the rapid repolarization caused by K+ efflux. 
1.4.3.2. MO2 and Heart Rate 
The rate of oxygen consumption (MO2) by an organism is a useful method for 
assessing metabolic rate. MO2 is often measured using swim tunnels or microplate 
respirometers. Due to the cost of these instruments, as well as the difficulty in measuring 
MO2, particularly during the embryonic stage, heart rate has been used as a surrogate 
measurement for metabolic rate.. A study by Folkerts et al., (2017), demonstrated that 
hydraulic fracturing flow-back and produce water caused a decrease in larval zebrafish 
heart rate. Using a Loligo® Microplate respirometer the authors also measured a decrease 
in MO2 of exposed larvae. This use of a respirometer in conjunction with monitoring heart 
rate indicates that an alteration in heart rate can correspond to a change in MO2. However, 
heart rate is still not a direct measurement of metabolism, and may be influenced by other 
factors. Fish are ectotherms and temperature can play a significant role in metabolic rate 




1.4.4.1. 17β-estradiol (E2) 
In vertebrates, steroid hormones are derived from cholesterol and are an important 
component of the endocrine system. In female fish, 17β-estradiol (E2) is a major 
reproductive steroid. E2 is known to influence behaviour, gonadal differentiation, and 
secondary sexual characteristics. The chemical properties of E2 are outlined in Table 2. A 
common biomarker for estrogen exposure in fish is induction of vitellogenin (VTG) in 
males (Kime, 1999). VTG is a yolk precursor protein normally only expressed in females 
and it is important in oocyte production (Kime, 1999). 
1.4.4.2. 17β-estradiol Regulation 
Reproductive hormones are primarily regulated through the hypothalamus-
pituitary-gonadal (HPG) axis in mammals, and the hypothalamus-pituitary-gonadal-liver 
(HPGL) axis in oviparous organisms (Arukwe and Goksøyr, 2003). In fish, gonadotropin 
releasing hormone (GnRH) is released from the hypothalamus, acting on the pituitary gland 
resulting in the release of gonadotropin 1(GtH1) and Gonadotropin 2 GtH2 (Arukwe and 
Goksøyr, 2003). Through plasma transport,GtH1 and GtH2 activate a G-protein mediated 
signal transduction within the gonads, inducing steroidogenesis in fish (Clark et al., 1994; 
Nakamoto et al., 2012). In excess, steroids will activate a negative feedback loop beginning 
in the hypothalamus and pituitary. This interruption inhibits the release of GnRH, 
interrupting the HPGL axis, thereby interrupting steroidogenesis and reducing the 
production of E2 in the ovaries (Kime, 1999; Arukwe and Goksøyr, 2003). 
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1.4.5. Estrogen Receptors 
Estrogen receptors are a group of proteins that utilize 17β-estradiol as a ligand for 
activation. There are two classes of estrogen receptors, nuclear estrogen receptors and 
membrane estrogen receptors. 
1.4.5.1. Nuclear Estrogen Receptors 
There are two nuclear estrogen receptors ERα and ERβ, both are ligand-dependent 
transcription factors and their activation often results in alterations in gene transcription 
(Delaunay et al., 2000; Romano et al., 2017). In brief, when ERα or ERβ are activated they 
homodimerize and interact with estrogen response elements located on target genes leading 
to alterations in gene transcription (Delaunay et al., 2000). This is often referred to as 
classical estrogen receptor signaling (Prossnitz and Barton, 2014). The mechanism of 
toxicity of EE2 has been focused on this classical estrogen receptor signaling (Jayasinghe 
and Volz, 2012). 
1.4.5.2. Membrane Estrogen Receptors 
Membrane estrogen receptors differ in that they are G protein-coupled receptors (GPCR) 
and are not ligand-dependent transcription factors. GPCRs are a group of receptors that 
when activated by many signaling molecules, such as hormones or neurotransmitters, 
initiate various rapid cellular responses (Jayasinghe and Volz, 2012). GPCRs consist of a 
seven transmembrane receptor coupled to a g-protein. g-proteins are made up of three 
subunits, α, β, and γ, the α and γ subunits are anchored into the plasma membrane 
(Trzaskowski et al., 2012). When inactivated the GPCR is bound to guanosine diphosphate 
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(GDP) which is also bound to the α-subunit of the g-protein. Upon activation by a ligand, 
a conformational change will occur, resulting in the α-subunit binding to guanosine 
triphosphate (GTP) instead of GDP resulting in the dissociation from the receptor and the 
β – γ dimer (Trzaskowski et al., 2012). Depending on the GPCR, the α-subunit, and the β 
– γ dimer will travel along the membrane altering other proteins (Trzaskowski et al., 2012). 
A prominent GPCR, and the receptor of interest for this research project is the G protein-
coupled estrogen receptor (GPER), formerly GPR30. 
1.4.5.2.1. G Protein-Coupled Estrogen Receptor (GPER) 
GPER is located in the membrane of the endoplasmic reticulum and is thought to 
be responsible for the some of the rapid non-genomic effects that E2 has on cells (Diamante 
et al., 2017). GPER activation leads to adenylyl cyclase stimulation and has been linked to 
increased levels of the secondary messengers, cyclic adenosine monophosphate (cAMP) 
and Ca2+ (Lin et al., 2013; Diamante et al., 2017). The mRNA expression of GPER (gper1) 
occurs throughout the body of vertebrates with higher levels found in the gonad, nervous 
system, and vasculature (Jayasinghe and Volz, 2012). GPER has been shown to play a 
significant role in the cardiovascular system of vertebrates (Jayasinghe and Volz, 2012; 
Diamante et al., 2017; Romano et al., 2017). In mice, GPER has been tied to ventricular 
hypertrophy, regulation of blood pressure and vascular tone, and atherosclerosis 
progression (Jayasinghe and Volz, 2012). 
One of the challenges in studying the role of GPER is differentiating the effects of 
GPER from the effects of classical nuclear estrogen receptor activation (Romano et al., 
2017). Romano et al., (2017) demonstrated the independence of GPER using embryonic 
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zebrafish. They observed that E2 can significantly increase embryonic heart rate of 
zebrafish at 3.67µM (1 mg/L). They used specific agonists and antagonists for GPER and 
nuclear estrogen receptors to understand the mode of action and determined that GPER 
activation, not membrane nuclear estrogen receptors, acutely regulated embryonic heart 
rate in zebrafish (Romano et al., 2017). This finding was confirmed though the use of 
mutant zebrafish. No change in heart rate was observed in nuclear estrogen receptor loss-
of-function embryos while a reduced heart rate occurred in maternal zygote gper1 
knockout zebrafish embryos (Romano et al., 2017). They also found that gper1 expression 
regulated thyroid hormone triiodothyronine (T3) in the pituitary; T3 is known to increase 
heart rate. Exposure of T3 to gper1 knockout zebrafish rescued the reduced heart rate, 
while E2 had no effect on these organisms (Romano et al., 2017).  This study demonstrated 
that GPER was able to act as an autonomous estrogen receptor and that T3 acts downstream 
of GPER to regulate heart rate in embryonic zebrafish (Romano et al., 2017). GPER 
activation is an understudied mode of action for estrogenic compounds and embryonic 
heart rate of fish appears to be a valuable endpoint to investigate it. 
1.4.5.3. Estrogen Receptor Agonists and Antagonists 
Several synthetic agonists and antagonists for both nuclear estrogen receptors and 
GPER exist. The chemical properties of the estrogen receptor agonists and antagonists are 
outlined in Table 1. G-1 was first characterized in 2006, and is a known selective GPER 
agonist displaying strong specificity for GPER and little to no affinity for ERα and ERβ 
(Bologa et al., 2006). Fulvestrant (ICI) is a known antagonist for ERα and ERβ, as well as 
an agonist for GPER.  G-36 is a selective antagonist for GPER, while PHTPP and ZK 
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164015 are selective antagonists for ERβ and ERα respectively (Table 1) (Prossnitz and 
Barton, 2014; Romano et al., 2017).
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Table 1: Chemical properties of select estrogen receptor agonists and antagonists, G-1, Fulvestrant, G-36, PHTPP, and ZK 164015. 
Data from: ChemDraw Professional V: 16.0.1.4(77), unless denoted ǂ (https://www.drugbank.ca/)
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C21H18BrNO3 C32H47F5O3S C22H22BrNO3 C20H11F6N3O C30H43NO4S 
Molecular 
Weight (g/mol) 
412.283 606.771 412.320 423.318 513.732 
Aqueous 
Solubility 
(mg/L at 25° C) 
0.8865 6.72 - 0.1112 - 
Log KOW 4.901 7.35 6.339 5.055 7.97 
pKa - -0.88 + 10.32 ǂ  9.832 10.115 
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1.5. Pharmaceuticals and Personal Care Products (PPCPs) 
PPCPs represent a very diverse group of chemical compounds used in human and 
veterinary pharmaceutical industries, as well as cosmetic and personal care products. The 
pharmaceutical industry has been reported to grow 7% annually, suggesting an increasing 
influent load at WWTPs (Corcoran et al., 2010; Monteiro and Boxall, 2010). Rising use 
and environmental presence of PPCPs has led to increased environmental concern. 
The major urban sources of PPCPs in the environment are wastewater treatment 
plants (WWTP) effluents (Yang and Metcalfe, 2006; Corcoran et al., 2010). 
Pharmaceuticals primarily enter wastewater through urine and fecal elimination by humans 
and livestock, as well as discarded medication (Rosi-Marshall and Royer, 2012). Personal 
care products, such as soaps and detergents often enter wastewater when rinsed off after 
use. Once in wastewater, PPCPs may enter the environment through WWTP effluent 
(Snyder et al., 2003). A consequence of WWTPs is the increase in effluent volume at a 
single outflow location. For example the Duffin Creek WWTP in Ajax Ontario, Canada 
serves approximately 1 million people from many surrounding municipalities, discharging 
into Lake Ontario an average of 340 million liters of treated effluent per day with the 
capacity to treat 630 million liters per day (Durham Region, 2013). A visual summary of 
the primary routes of PPCP entry into the environment can be found in Figure 1. 
Typically, WWTPs do not have a dedicated step to remove PPCPs which are also 
deemed to be pseudo-persistent (Rosi-Marshall and Royer, 2012). The continual release of 
PPCPs allows for the maintenance of surface water concentrations even if the compound 
is not inherently persistent, resulting in surface water concentrations in the ng/L - µg/L 
range (Durán-Alvarez et al., 2009). Recent advances in WWTP operational processes, 
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specifically nitrifying activated sludge, have reduced the effluent estrogenicity (McAdam 
et al., 2010; Hicks et al., 2017). A WWTPs redox potential, and retention times, hydraulic 
and solid, has been known to impact the efficiency of estrogen removal (Koh et al., 2008). 
The following sections will review two of the PPCPs of interest for this thesis, 17α-
ethinylestradiol (EE2) and hydroxypropyl-β-cyclodextrin (HPβCD), with emphasis on the 
physiological systems that are most affected. These PPCPs were chosen to be studied due 
to the ability for HPβCD to include EE2, as well as the potential to determine the effects 







Figure 1: Primary routes of pharmaceuticals and personal care products (PPCPs) into the 
environment (image from Overturf et al., 2015).
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1.6. PPCPs of Interest 
The following sections will outline the chemical properties, biological activity and 
toxicity of EE2 and HPβCD. EE2 was chosen based on its ubiquitous presence in the 
environment, and its ability to induce a biological response. Although the environmental 
concentration of HPβCD is currently unknown, it was selected due to its high prevalence 
in detergents and odour suppressants, and its ability to interact with EE2 (Tang et al., 2018). 
1.6.1. 17α-Ethinylestradiol (EE2) 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol) is a nonpolar 
hydrophobic synthetic agonist for estrogen receptors. The chemical properties of EE2 are 
outlined in Table 2. EE2 is the primary estrogen used in combined oral contraceptives and 
hormone replacement therapy. In humans, EE2 has been reported to have one to two times 
greater affinity for nuclear estrogen receptors and up to five times greater affinity for 
nuclear estrogen receptors in some fish species than E2 (Aris et al., 2014). 
Frequent use has made EE2 a common contaminant in surface waters. It primarily 
enters through WWTPs, septic systems, and agricultural runoff (Aris et al., 2014). 
Focusing on WWTPs, EE2 is excreted as free EE2 or as a glucuronide-EE2 conjugate after 
human consumption, and enters WWTPs. Due to its stability, minimal degradation of EE2 
occurs in the WWTP, however, bacterial de-conjugation of EE2-glucuronides may occur 
(Andersen et al., 2003; Parrott and Blunt, 2005; Aris et al., 2014). Contaminated effluent 
is then released into surface waters with resulting EE2 concentrations in the low ng/L range 
(Kolpin et al., 2002; Aris et al., 2014). In recent years, upgrades to the Kitchener WWTP, 
have helped reduce effluent estrogen equivalents (Hicks et al., 2017). However, due to the 
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high biological activity and presence in the aquatic environment, the toxicity of EE2 to 
non-target organisms has been and will continue to be extensively studied (Aris et al., 




 Table 2: Chemical properties of 17β-Estradiol (E2) and 17α-Ethinylestradiol (EE2) 
  
- Data obtained from https://www.drugbank.ca/; pKa values are predicted. 
 
17β-Estradiol (E2) 17α-Ethinylestradiol (EE2) 
Chemical Structure 
  
Molecular Formula C18H24O2 C20H24O2 
Molecular Weight (g/mol) 272.382 296.403 
Aqueous Solubility (mg/L at 27° C) 3.6 11.3 
Log KOW 4.01 3.67 
pKa 0.88 and 10.33 -1.7 and 10.33 
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1.6.1.1. EE2 Mode of Action 
In humans, the proposed mode of action of oral contraceptives is through the 
activation of nuclear estrogen receptors in the pituitary and hypothalamus. This initiates a 
negative feedback loop along the hypothalamus-pituitary-gonadal (HPG) axis, thereby 
inhibiting the production of gonadotropin releasing hormone (GnRH). A reduction of 
GnRH limits the production of follicle stimulating hormone (FSH) and luteinizing 
hormone (LH), GtH1 and GtH2 in fish, from the pituitary gland, (Rivera et al., 1999; 
Mateos et al., 2002). This reduces the production of endogenous estrogen 17β-estradiol 
(E2) and inhibits mid-cycle peaks (Rivera et al., 1999; Mateos et al., 2002). This results in 
the inhibition of oocyte maturation and ovulation, thereby reducing the likelihood of 
conception in women (Rivera et al., 1999). 
A novel EE2 mode of action is though the activation of G protein-coupled estrogen 
receptor (GPER). Little is known about the impact of GPER activation by EE2 in 
mammalian models. To the best of our knowledge, no studies have examined the impact 
of GPER activation by EE2 in fish. Understanding another mechanism of action for EE2 
is important for understanding the risk posed to non-target organisms. The role and 
regulation of E2 and GPER is outlined in greater detail in Section 1.4.4. 
1.6.1.2. Toxicity of EE2 to Fish 
In fish, EE2 is a potent toxicant, significantly influencing both fecundity and 
secondary sexual characteristics. Effects on fecundity appear to be bi-modal and dependent 
on concentration (reviewed by Overturf et al., 2015). In a 21 day exposure of mature 
fathead minnows (Pimephales promelas), EE2 increased egg production at 0.1 ng/L and 1 
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ng/L, however a significant decrease was observed at 100 ng/L in the same study 
(Pawlowski et al., 2004). This is supported by other studies with varying exposure lengths 
and test species. In fathead minnows exposed for their full life-cycle, an increase in egg 
production was observed at 0.32 ng/L and 0.96 ng/L, which was contrasted with a cessation 
of egg production when exposed to concentrations greater than 3.5 ng/L (Parrott and Blunt, 
2005). A study that exposed adult Japanese medaka for 14 days to EE2, also observed an 
increase in fecundity at 0.2 ng/L EE2 and a reduction at 500 ng/L EE2 (Tilton et al., 2005). 
In each of the three studies listed above, a reduction in fertilization was observed 
upon EE2 exposure, indicating potential male reproductive impairment. This was 
supported by the feminization of male sexual and secondary sexual characteristics observed 
in studies by Parrot & Blunt (2005) and Pawlowski et al., (2004), and a whole lake 
population collapse as reported by Kidd et al., (2007).  
In an attempt to characterize the environmental relevance of EE2 toxicity in wild 
fish, Kidd et al., 2007, conducted a 7 year whole lake study in the Experimental Lakes 
Area in Northwestern Ontario, Canada. They exposed the lake to 5-6 ng/L EE2 and 
observed an induction in VTG in both male and female fathead minnows, and the 
development of intersex gonads in male testicular tissue (Kidd et al., 2007). This exposure 
led to the near extinction of fathead minnows from the lake. Interestingly however, by the 
spring of the fourth year post EE2 treatment, the number of fathead minnows returned back 
to baseline and testicular abnormalities were not present (Blanchfield et al., 2015). 
EE2 toxicity to fish is extensive and shows significant impacts to apical endpoints. 
Effects have been primarily focused on nuclear estrogen receptor activation along the 
HPGL axis in fish. Many studies attempt to explain observed toxicity to changes in genetic 
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expression or protein abundance. To date no studies have investigated the toxicity of EE2 
to membrane estrogen receptors in fish, specifically GPER. This may be a novel mode of 
action for EE2 since environmental estrogens have been shown to activate GPER (Thomas 
and Dong, 2006). 
As described above, GPER activation is a non-genomic mode of action that may 
result in different avenues of toxicity. An example of a GPER mediated endpoint is 
embryonic heart rate. Currently only one study has examined the impact of EE2 on fish 
heart rate. This study observed a significant decrease in embryonic heart rate of zebrafish 
exposed to 0.4 ng/L EE2 (Santos et al., 2014). These results are supportive of the finding 
that EE2 results in reduced blood circulation in embryonic medaka (Schiller et al., 2014). 
However, it contradicts the observed impact of E2 which at 1 mg/L resulted in an increase 
in embryonic zebrafish heart rate (Romano et al., 2017). Although they are different 
compounds, structural similarity and the ability of both chemicals to activate GPER 
suggests that their toxicity may be related (Table 2). A potential explanation for this 
discrepancy could be the bi-modal effects that are often observed with estrogen receptor 
activation. In these experiments, the E2 exposure was approximately 1 million times 
greater than the EE2 exposure. It is important to note that concentrations in the low ng/L 
range are more representative of what is observed in surface waters. One research objective 
of this thesis is to better understand the toxicity of EE2 to the embryonic heart rate of fish 




 Cyclodextrins are a class of α-(1,4) cyclically linked glucopyranose 
oligosaccharides. Cyclodextrins are most commonly present as either α, β, or γ containing 
6, 7, or 8 glucopyranose subunits, respectively (Table 3) (Del Valle, 2004). The resulting 
toroidal configuration of the cyclodextrin molecule has been proven to be a very useful 
binding cavity (Szejtli, 1998; Davis and Brewster, 2004). Binding within the central cavity 
of the cyclodextrin molecule is known as “guest inclusion” where the guest molecule is 
non-covalently bound to the cyclodextrin cavity and is reversible. Contributing to the utility 
of cyclodextrins is that they are amphiphilic since the outer portion of the toroid is more 
hydrophilic than the cavity (Szejtli, 1998). This encourages passive non-covalent inclusion 
of whole lipophilic molecules or lipophilic moieties of those molecules in the cavity of 
cyclodextrins in an aqueous solution (Szejtli, 1998; Loftsson and Brewster, 2012). 
Inclusion within the cyclodextrin compound has been shown to dramatically improve the 
aqueous solubility of poorly soluble compounds (Loftsson and Brewster, 2012). 
Cyclodextrins are currently used in odour control sprays, solubilizers, and excipients in the 
pharmaceutical industry (Loftsson and Brewster, 2012). As of 2012, cyclodextrins are have 
been used in 35 different pharmaceuticals (Loftsson and Brewster, 2012). 
1.6.2.1. Hydroxypropyl-β-Cyclodextrin (HPβCD) 
Of the three conformations of cyclodextrins, α, γ, and β, the β conformation has the 
most useful cavity size. However, β-cyclodextrin is the least water soluble, which limits its 
ability to solubilize guests (Loftsson and Brewster, 2012). As a result, modifications have 
been made to β-cyclodextrin by adding hydroxypropyl side chains, creating 
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hydroxypropyl-β-cyclodextrin (HPβCD). This addition increased the polarity of the outer 
region of the toroid thus improving the aqueous solubility (Table 3) (Szejtli, 1998; Loftsson 
and Brewster, 2012). HPβCD is currently used as an excipient in the pharmaceutical 
industry, and as the active ingredient in the deodourizer Febreze®. HPβCD can be found 
in oral, parenteral, rectal, and ophthalmic drugs, primarily increasing the solubility and 
bioavailability of the active pharmaceutical (Loftsson and Brewster, 2012). Although the 
theoretical inclusion of guests occurs at a 1 : 1 molar ratio with HPβCD, a review of 
inclusion efficiencies mentions that the optimal molar ratio for most guests is 
approximately 4 : 1, HPβCD : Guest (Loftsson and Brewster, 2012). With minimal clinical 
side effects and a low oral bioavailability of 3 %, HPβCD has generally been deemed safe 




Table 3: Chemical properties, and cavity dimensions of α, β, and γ – cyclodextrin. Modified from (Szejtli, 1998; Loftsson and Brewster, 
2012). 
Property α β γ HPβCD 
Number of Glucopyranose Units 6 7 8 7 
Molecular Weight (g/mol) 972 1135 1297 1396 
Aqueous Solubility * 14.5 1.85 23.2 45 
Cavity Diameter (Å) 4.7-5.3 6.0-6.5 7.5-8.3 6.0-6.5 
Height of Torus (Å) 7.9 ± 0.1 7.9 ± 0.1 7.9 ± 0.1 7.9 ± 0.1 
Approximate Cavity Volume (Å3) 174 262 427 262 
* Solubility represented as g per 100 ml of water at room temperature. 
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1.6.2.2. HPβCD Toxicity to Fish 
Environmental concern has risen with the increase in the use of HPβCD in 
pharmaceuticals and as deodourizers in laundry detergents. However, to the best of our 
knowledge, neither effluent of surface water concentrations are known. To date, there has 
only been one study that has examined the environmental impacts of HPβCD to fish. This 
study exposed American flagfish (Jordanella floridae) to HPβCD for their complete life-
cycle (Anderson et al., 2016). It was observed that there was no impact to fecundity, 
however, an increase in female gonadosomatic index (GSI) was observed at 5 µg/L. 
Furthermore, a decrease in offspring growth and tolerance to copper was observed after 
parental exposure to HPβCD (Anderson et al., 2016). Currently, the mechanism behind 
this increase in female GSI is not understood. However, there is potential that HPβCD is 
complexing with endogenous steroid hormones and or pheromones.  
1.6.2.3. HPβCD and EE2 
HPβCD forms complexes with estrogens in aqueous solutions (Pérez and Escandar, 
2013). EE2 has a greater stability and a higher association constant with HPβCD relative 
to endogenous estrogens (Pérez and Escandar, 2013). This can be attributed to the greater 
hydrophobicity of EE2 (Table 2). Stability typically improves with increased 
hydrophobicity of the guest molecule (Pérez and Escandar, 2013). 
Given the low water solubility of EE2, organic solvents are often used as a carrier 
when assessing their toxicity in an aquatic setting. However, complexation between EE2 
and HPβCD is reduced in the presence of organic solvents. Organic solvents have the 
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ability to interact with the binding cavity of cyclodextrins, disrupting stability. These 
effects are most prominent at organic solvent concentrations greater than 20 % V/V (Pérez 
and Escandar, 2013). It is recommended that for aquatic toxicity studies organic solvents 
used as carriers should be no greater than 0.01 % V/V. The influence of organic solvents 
to the inclusion of EE2 into HPβCD in these studies is expected to be minimal, however, 
the possibility should still be taken into consideration. 
Recent interest in the ability of HPβCD to influence the toxicity of guest 
compounds has increased. It has been shown that HPβCD can suppress the estrogenic 
effects of E2 in a yeast two-hybrid assay (Oishi et al., 2008). HPβCD had no impact on E2 
estrogen receptor affinity in this study, suggesting that HPβCD may be blocking E2 from 
crossing biological membranes (Oishi et al., 2008).
34 
 
1.7. General Materials and Methods 
1.7.1. Animal Husbandry 
Below is a brief description of the animal husbandry that took place during this 
study. The breeding stock of medaka were held and maintained under the approved animal 
usage protocol number AUP 14-002, by the Animal Care Committee at the University Of 
Ontario Institute Of Technology, Oshawa, Ontario, Canada. All animal care was 
conducted in accordance with the Canadian Council on Animal Care (CCAC). 
1.7.1.1. Lab Water Process and Lighting 
Unless otherwise stated, the 25° C laboratory water used to house fish for this 
project consisted of municipal water (Oshawa, Ontario), de-chlorinated via charcoal and 
resins, and buffered with calcium carbonate. After treatment, the water is pumped to a 
header tank above the laboratory, heated to 25° C, and then gravity fed down to the aquaria. 
A ball valve on the incoming water line regulates the flow into the aquaria, and stand pipes 
allow for water to exit into a trough. The flows are typically set to 5 turnovers per day, 
resulting in a > 99 % molecular turnover per day (Sprague, 1969). 
The laboratory experienced a 16 hour light and 8 hour dark photoperiod including 
a half hour dawn and dusk period included in the light phase. Lighting consisted of full 




1.7.1.2. Japanese medaka 
Japanese medaka (FLFII) were originally obtained from the National Institute for 
basic Biology (Okazaki, Japan). The general lab population of medaka were housed in 25 
± 1° C, 70 L flow though aquaria at a density of approximately 0.5 fish per L. They were 
fed TetraminTM Pro Flake (Tetra United Pet Group), (minimum crude protein of 46.0 %, 
12.0 % crude fat, 3.0 % crude fiber, 1.1 % phosphorus, 200 mg/kg ascorbic acid, and 
maximum moisture of 8.0 %) flake food and freshly hatched brine shrimp nauplii twice per 
day. Premium brine shrimp eggs were purchased from Brine Shrimp Direct (Ogden, Utah, 
USA). 
Once fish reach sexual maturity they were separated into breeding harems 
consisting of 15 males and 15 females per 70 L aquarium. Egg collection occurred once 
per day, any females carrying eggs were netted and the clutch of eggs gently removed 
before returning the fish to the aquarium. Additionally, all of the greenery in the tanks was 
removed, inspected for deposited egg clutches, rinsed and returned to the aquarium. Water 
from the breeding aquaria was then siphoned into a shallow bucket and any loose eggs 
kept. The eggs were then rolled on a wetted piece of paper towel to reduce the adherence 
of the attaching filaments that cover the eggs. The eggs were then placed in 150 mL 
crystallization dishes containing rearing solution comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
The crystallization dishes were placed in a 27° C temperature control room on an Advanced 
Digital Skater (VWR International, Mississauga, Ontario, Canada) set to 60 RPM to 
ensure uniformity of hatching time. After 24 h of incubation, any unfertilized eggs 
characterized by a blue colouration were removed. The remaining embryos were either left 
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to develop until hatch 9 – 11 days post fertilization and used to restock the lab population, 
or used in an embryonic toxicity test. Embryonic toxicity test protocol is outlined in the 
following sections. For the laboratory population, hatched fry were placed in a 20 L flow 
through aquaria and fed as described above. Once they reached an average length of 
approximately 1 cm, they were transferred into 70 L aquaria at a density of 0.5 fish per L 
until sexual maturity. 
1.8. General Aims, Rationale, and Knowledge Gaps 
The overall goals of this research thesis were to better understand the non-classical 
toxicity pathways of estrogens in teleost fish, and the influence of the deodourizer 
(HPβCD) on EE2 toxicity. This project was broken down into three major aims, each of 
which are described in brief below, and in greater detail in chapters 2 – 4. 
The first major aim was to determine if EE2 could alter the embryonic heart rate of 
Japanese medaka. There has been evidence that E2 can influence embryonic heart rate 
through GPER activation in embryonic zebrafish. EE2 can act as a ligand for GPER, 
suggesting that GPER may be a novel mechanism of action of EE2 in fish. To the best of 
our knowledge, only one study has reported a decrease in heart rate following EE2 
exposure to zebrafish embryos at environmentally relevant concentrations. We also wanted 
to determine if specific GPER agonism or antagonism can modulate embryonic heart rate 
in Japanese medaka. 
The second major aim was to determine if HPβCD could alter the above observed 
toxicity to embryonic medaka. HPβCD has been shown to include EE2 as a guest, however, 
alterations in guest toxicity to non-target organisms has yet to be understood. To the best 
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of our knowledge, there has only been one study examining the toxicity of HPβCD alone 
to fish (Anderson et al., 2016). This research will help elucidate the influence of HPβCD 
on the toxicity of other known toxicants, and is important to the field of aquatic toxicology 
as it will help further the understanding of the combinatorial toxicity of PPCPs. 
Finally, the last aim of this project was to determine if the observed alterations in 
embryonic heart rate caused by the exposure to EE2 result in metabolic changes within the 
organism. Heart rate is commonly used as a surrogate measurement for metabolic rate. 
Through the use of a microplate respirometer, we aimed to determine if the observed 












2. Chapter 2: EE2 and HPβCD Impact on Embryonic Heart Rate 
2.1. Introduction 
The consumption of pharmaceutical and personal care products continually 
increases annually. Over the last two decades, research into the toxicological effects of 
these compounds in non-target organisms has been extensive. Very few pharmaceutical 
compounds have been as well studied from an environmental perspective as 17α-
ethinylestradiol (EE2) (Andersen et al., 2003; Parrott and Blunt, 2005; Kidd et al., 2007; 
Aris et al., 2014; Overturf et al., 2015). It has been repeatedly demonstrated that EE2 
interferes with fertility and fecundity in many fish species through interference in the 
hypothalamus pituitary gonadal axis (Rivera et al., 1999; Mateos et al., 2002). Activation 
of nuclear membrane estrogen receptors ERα and ERβ is known as classical estrogen 
signaling (Prossnitz and Barton, 2014). This mode of action typically results in the 
alteration of estrogen related genes, often leading to the presence of female secondary 
sexual characteristics in genotypic males. These effects are often slower to appear due to 
the inherent time it takes for gene up or down regulation, transcription, and translation into 
respective proteins (Prossnitz and Barton, 2014). The effects of EE2 toxicity through 
classical estrogen signaling can be significant at very low concentrations, and they are often 
the result of chronic exposure (Kidd et al., 2007; Overturf et al., 2015). 
Recently, the characterization of the G protein coupled estrogen receptor (GPER) 
has provided an alternative mode of action for E2 (Romano et al., 2017). GPER is a 
membrane bound estrogen receptor that is located on the sarcoplasmic reticulum (Prossnitz 
and Barton, 2014; Diamante et al., 2017). Due to the nature of G Protein coupled receptors, 
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the cellular response is often more immediate (Gaudet et al., 2015; Diamante et al., 2017; 
Sharma et al., 2018). GPER has been localized to many tissues within vertebrate models, 
and one of the more prominent localizations of GPER is in the cardiovascular system 
(Sharma et al., 2018). Activation of GPER has been shown to alter heart rate as well as 
blood flow in embryonic zebrafish (Santos et al., 2014; Romano et al., 2017). The heart 
rate of embryonic zebrafish exposed to 1 mg/L E2 increased while 0.4 ng/L EE2 resulted 
in a decrease (Santos et al., 2014; Romano et al., 2017). It was further demonstrated that 
the increase in heart rate was the result of GPER activation and not classical estrogen 
signaling at high concentrations of E2 (Romano et al., 2017). 
The primary goal of this research was to understand the impact of environmentally 
relevant concentrations of EE2 on the heart rate of embryonic Japanese medaka. Previous 
research had indicated that GPER activation can increase heart rate at high concentrations, 
however the mechanism of action for low levels of EE2 causing decreased heart rate had 
not been investigated. The effects of such low level toxicity through a novel mode of action 
is very valuable for understanding the full sub-lethal effects of EE2 within the environment. 
In addition to investigating the influence of GPER on embryonic heart rates, the 
ability of hydroxypropyl-β-cyclodextrin (HPβCD) to alter the observed toxicity of EE2 
was also examined. HPβCD is an odour suppressant and an excipient commonly used in 
detergents and in drug delivery systems (Szejtli, 1998; Del Valle, 2004; Loftsson and 
Brewster, 2012). It exhibits a toroidal structure with amphiphilic properties, the inner 
region being hydrophobic while the outer region is hydrophilic (Szejtli, 1998). The 
structure and variance in hydrophobicity creates a cavity that other hydrophobic 
compounds may bind to, aiding in solubility (Szejtli, 1998). Cyclodextrins are thought to 
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be non-toxic and are often used to aid in the distribution of drugs throughout the body 
through inclusion (Del Valle, 2004). They are also popular in odour suppressants as they 
can encapsulate molecules, preventing them from interacting with olfactory receptors (Del 
Valle, 2004). It is hypothesized HPβCD can include EE2 potentially preventing it from 
entering the embryo or interacting with receptors (Oishi et al., 2008; Pérez and Escandar, 




2.2. Objectives, Knowledge Gaps, Rationale, and Hypotheses 
2.2.1. Objective 1: Embryonic Heart Rate: EE2 and HPβCD – Pilot Studies 
The goal of objective 1 was to determine if EE2 exposure can alter the heart rate of 
embryonic Japanese medaka. Evidence suggests that EE2 can activate GPER and GPER 
can regulate embryonic heart rate in zebrafish. We aimed to determine an effect 
concentration for this endpoint. Additionally, we wanted to determine if HPβCD has the 
ability to alter any EE2 induced changes in embryonic heart rate. 
The null hypotheses for this experiment were: 
H0: There is no difference between the heart rates of embryonic Japanese 
medaka exposed to EE2 versus the carrier control. 
H0: There is no difference between the heart rates of embryonic Japanese 
medaka exposed to EE2 versus EE2 + HPβCD. 
2.2.2. Objective 2: Sex Comparison 
The goal of objective 2 was to compare male and female embryonic heart rates 
following exposure to EE2. The FLFII strain of Japanese medaka presents the unique 
ability for researchers to determine sex as early as 48 hpf. Given that EE2 is a potent 
estrogen, there exists the potential that EE2 exposure may result in differential impacts to 
the heart rates of embryonic male and female medaka. This research was aimed at reducing 
variability in the data and identifying sex specific effects of EE2 on embryonic heart rates. 
The null hypotheses for this experiment were: 
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H0: There is no difference between the heart rates of male and female embryonic 
Japanese medaka following an exposure to EE2. 
H0: There is no difference between the heart rates of embryonic Japanese 
medaka exposed to EE2 versus the carrier control. 
2.2.3. Objective 3: ERα, ERβ, and GPER Agonist and Antagonist Impact on 
Embryonic Heart Rate. 
Objective 3 was completed to establish the mode of action of EE2 on embryonic 
heart rates. Data suggests that GPER activation is responsible for the alteration in heart 
rates of embryonic zebrafish (Romano et al., 2017). This study aimed at confirming these 
results with embryonic Japanese medaka exposed to agonists and antagonist of ERα, ERβ, 
and GPER alone and in combination with EE2. 
The null hypothesis for this study was: 
H0: The agonist, antagonists, or EE2 have no impact on the heart rate of 
embryonic Japanese medaka. 
2.2.4. Objective 4: The Influence of HPβCD on EE2 Toxicity 
The aim of objective 4 was to determine the optimal ratio of EE2:HPβCD. By 
exposing medaka to a range of EE2:HPβCD ratios, the identification of a concentration 





The null hypothesis for this experiment were: 
H0: There is no difference between the heart rate of embryonic Japanese medaka 
exposed to various ratios of EE2 and HPβCD. 
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2.3. Materials and Methods 
2.3.1. Objective 1: Embryonic Heart Rate: EE2 and HPβCD – Pilot Studies 
2.3.1.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), was dissolved in acetone. EE2 alone treatments were 
made through serial dilutions with rearing solution as the diluent. For the first pilot study, 
an EE2 alone rangefinder, final concentrations of 5, 50, 500, 5000, and 50000 ng/L of EE2 
were prepared. For the EE2 + HPβCD pilot study, final nominal concentrations of 0 ng/L 
(carrier control), 0.1 ng/L, 1 ng/L, 10 ng/L, 100 ng/L, and 1000 ng/L EE2 were made. 
HPβCD, 97.0 %, was purchased from Acros Organics (Thermo-Fisher Scientific), and 
dissolved in deionized water. HPβCD alone treatments were also made using serial 
dilutions with rearing solution as a diluent with final nominal concentrations set at 4x molar 
concentration of EE2 alone, corresponding to 0 ng/L (carrier control), 1.7 ng/L, 17 ng/L, 
170 ng/L, 1700 ng/L and 17000 ng/L HPβCD. EE2 + HPβCD treatments were made using 
the same methodology listed above with final nominal concentrations of combination 0 + 
0 ng/L (carrier control), 0.1 + 1.7 ng/L, 1 + 17 ng/L, 10 + 170 ng/L, 100 + 1700, and 1000 
+ 17000 ng/L EE2 + HPβCD. A summary of exposure concentrations can be found in Table 
4. A carrier control of 0.01 % v/v acetone was used, and this concentration of acetone was 
kept constant across all treatments. Solutions were made 24 hours prior to initial exposure 




Table 4: Range finding study nominal treatment concentrations of 17α-ethinylestradiol (EE2) alone, hydroxypropyl-β-cyclodextrin 
(HPβCD) alone, and a mixture of EE2 + HPβCD exposed to embryonic Japanese medaka (O. latipes). 




0 0 0 + 0 0.01 15 1 
0.1 1.7 0.1 + 1.7 0.01 15 1 
1 17 1 + 17 0.01 15 1 
10 170 10 + 170 0.01 15 1 
100 1700 100 + 1700 0.01 15 1 
1000 17000 1000 + 17000 0.01 15 1 
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2.3.1.2. Organisms and Experimental Procedure 
Adult Japanese medaka (FLFII), originally obtained from the National Institute for 
basic Biology (Okazaki, Japan) were bred in house as described in section 1.7.1.2. 
Collected embryos were reared in rearing solution, section 1.7.1.2, inside a 27˚ C 
temperature control room with a 16h:8h light:dark photoperiod and 0.5 h of dawn and dusk 
included in the light phase. 
For the EE2 alone pilot study, 6 hpf embryos were exposed to 0, 5, 50, 500, 5000, 
and 50000 ng/L EE2 in 6 well plates. There were 3 replicates per treatment with 9 embryos 
per replicate. The heart rate of each embryo was measured at 120hpf. Heart rate was 
determined by placing all embryos from a randomly selected replicate on a petri dish, and 
allowing to acclimate for 2 minutes before viewing under a Leica stereo microscope (Leica, 
Concord, Ontario, Canada). The number of heart beats that occurred in 15 seconds for 
each embryo was determined and then converted to beats per minute by multiplying by 
four. To normalize the data, the percent difference from the respective carrier control was 
calculated and used for analysis (Equation 1). 
There were three treatment groups for the EE2 and HPβCD range finding study: 
EE2 alone, HPβCD alone, and EE2 and HPβCD. At 6 hpf, the embryos were separated and 
exposed to the various treatment groups (Table 4) in a single six well plate with 15 embryos 
per treatment. Each well contained 10 ml of exposure solution and was changed once every 
24 hours. Heart rate was monitored one every 24 hours from 72 – 196 hpf. 
Data were analyzed by calculating the mean heart rate in beats per minute for each 
treatment and tested for normality and homogeneity. A two-way ANOVA with a Dunnett’s 
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post hoc test was used to determine differences from the respective carrier control as well 
as any differences between HPβCD, EE2, and EE2 + HPβCD treatments. All statistics were 







% 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑜𝑓 𝐶𝑎𝑟𝑟𝑖𝑒𝑟  𝐶𝑜𝑛𝑡𝑟𝑜𝑙 = ((
𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝐻𝑒𝑎𝑟𝑡 𝑅𝑎𝑡𝑒
𝑀𝑒𝑎𝑛 𝐻𝑒𝑎𝑟𝑡 𝑅𝑎𝑡𝑒 𝑜𝑓 𝐶𝑎𝑟𝑟𝑖𝑒𝑟 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
) ∗ 100) − 100 
 
Equation 1: Calculation of the % difference in heart rate from carrier control. Where treatment heart 
rate is the heart rate from an individual embryo in beats per minute, and the mean heart rate of carrier 
control is the average heart rate of the carrier control in beats per minute.
50 
 
2.3.2. Objective 2: Sex Comparison 
2.3.2.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), was dissolved in acetone. EE2 treatments were made 
through serial dilutions with rearing solution as the diluent, and final nominal 
concentrations of 0 ng/L (carrier control), 0.1 ng/L, 1 ng/L, 10 ng/L, 100 ng/L, and 1000 
ng/L EE2 were made. Acetone was kept constant in all treatments at a concentration of 
0.01 % v/v. Solutions were made 24 hours prior to exposure and stored in amber glass 
bottles in a 27° C temperature control room for the duration of the experiment. A summary 
of exposure concentrations can be found in Table 5. 
2.3.2.2. Experimental Procedure 
Embryonic Japanese medaka were obtained and maintained as described in section 
1.7.1.2. At 24 hpf, 20 embryos per treatment were exposed in a 6 well plate to a range of 
EE2 concentrations, 10 ml per well. At 72 hpf, the sex of each embryo was determined 
using a Leica DM2000 Fluorescence Microscope (Leica, Concord, Ontario, Canada), and 
separated into male and female exposures. Embryos were thinned to 7 embryos per sex per 
treatment per replicate (Table 5). 
Embryonic heart rate was monitored once every 24 hours beginning at 120 hpf and 
ending at hatch (216 hpf). Heart rate was determined by placing all 7 embryos from a 
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randomly selected single treatment on a petri dish. The embryos were acclimated for 2 
minutes before viewing under viewed under a Leica stereo microscope (Leica, Concord, 
Ontario, Canada). The number of heart beats that occurred in 20 seconds was determined 
and then converted to beats per minute by multiplying by three. The percent difference 
from the carrier control was calculated and used for analysis (Equation 1). This 
experimental procedure was replicated independently three times. 
Data were analyzed by calculating the mean heart rate in beats per minute for each 
treatment group and compared using an ANOVA. If the data was not normally distributed, 
a Kruskal-Wallis one way ANOVA on ranks test was completed. An all pairwise multiple 
comparison Tukey post hoc test was used to determine differences between treatments. All 





Table 5: Exposure summary for Objective 2: sex comparison.  Nominal concentrations of 17α-ethinylestradiol (EE2) exposed to male 
and female embryonic Japanese medaka (O. latipes), number of replicates, and number of embryos per replicate per sex. 
Treatment # [EE2] (ng/L) Acetone (%) Number of replicates  Number of embryos per replicate per sex 
1 0 0.01 3 7 
2 0.1 0.01 3 7 
3 1 0.01 3 7 
4 10 0.01 3 7 
5 100 0.01 3 7 
6 1000 0.01 3 7 
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2.3.3. Objective 3: ERα, ERβ, and GPER Agonists and Antagonists Impact on 
Embryonic Heart Rate 
2.3.3.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), G-1 (rel-1-[4-(6-bromo-1,3-benzodioxol-5-yl)-
3aR,4S,5,9bS-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone) from Cayman 
Chemical (Ann Arbor, Michigan, USA), Fulvestrant (ICI) ((7α,17β)-7-[9-[4,4,5,5,5-
Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol) from Toronto Research 
Chemicals inc. (Toronto, Ontario, Canada), G-36 ((4S)-rel-4-(6-bromo-1,3-benzodioxol-
5-yl)-3aR,4,5,9,bS-tetrahydro-8-(1-methylethyl)-3H-cyclopenta[c]quinolone) from 
Cayman Chemical (Ann Arbor, Michigan, USA), PHTPP (4-[2-Phenyl-5,7-
bis(trifluoromethyl)pyrazolo[1,5-a]-pyrimidin-3-yl]phenol-2-phenyl-3-4hydroxyphenyl)-
5,7-bis(trifluoromethyl)-pyrazolo[1,5-a]pyrimidine) from Sigma-Aldrich (Oakville, 
Ontario, Canada), and ZK 154015 (2-(4-Hydroxyphenyl)-3-methyl-1-[10-
(pentylsulfonyl)decyl]-1H-indol-5-ol) from Tocris (Oakville, Ontario, Canada), were 
dissolved in acetone. Treatments of each chemical (EE2, G-1, Fulvestrant (ICI), G-36, 
PHTPP, and Zk 164015), were made through serial dilutions with rearing solution as the 
diluent. Final nominal concentrations for each compound were, 10 ng/L, and 100 ng/L with 
0.01 % v/v acetone being kept constant in all treatments. Solutions were made 24 hours 
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prior to exposure and stored in amber glass bottles in a 27° C temperature control room for 
the duration of the experiment. 
2.3.3.2. Experimental Procedure 
Below is the general procedure for each agonist/antagonist, this procedure was 
conducted for G-1, Fulvestrant (ICI), G-36, PHTPP, and ZK 16405. 
Embryonic Japanese medaka were obtained and maintained as described in section 
1.7.1.2. At 24 hpf, 7 embryos per treatment were exposed in a 6 well plate to a carrier 
control (0.01 % v/v acetone), 10 ng/L EE2, 10 ng/L agonist or antagonist, 100 ng/L 
agonist/antagonist, 10 ng/L EE2 + 10 ng/L agonist/antagonist, 10 ng/L EE2 + 100 ng/L 
agonist/antagonist, with 10 ml of treatment solution per well. At 48 hpf, embryos were 
thinned to 7 embryos per replicate with three replicates per treatment (Table 6). 
Embryonic heart rate was monitored once every 24 hours beginning at 120 hpf and 
ending at hatch (192–216 hpf). Heart rate was determined by placing all 7 embryos from a 
randomly selected single treatment on a petri dish. The embryos were acclimated for 2 
minutes before viewing under viewed under a Leica stereo microscope (Leica, Concord, 
Ontario, Canada). The number of heart beats that occurred in 20 seconds was determined 
and then converted to beats per minute by multiplying by three. The percent difference 
from the carrier control was calculated and used for analysis (Equation 1). 
Data were analyzed by calculating the mean heart rate in beats per minute for each 
treatment group and compared using an ANOVA for Fulvestrant, G-36, and PHTPP 
experiments. Data was not normally distributed in the G-1 and ZK 16405 experiments, and 
a Kruskal-Wallis one way ANOVA on ranks test was completed. An all pairwise multiple 
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comparison Tukey post hoc test was used to determine differences between treatments. All 




Table 6: Exposure summary for Objective 3: ERα, ERβ, and GPER agonists and antagonists. Nominal concentrations of 17α-
ethinylestradiol (EE2), and agonist/antagonist (G-1, Fulvestrant (ICI), G-36, PHTPP, or ZK 164015) exposed to embryonic Japanese 
medaka (O. latipes), number of replicates, and number of embryos per replicate. 
Treatment # [EE2] (ng/L) [Agonist/Antagonist] (ng/L) Acetone (%) Number of replicates  Number of embryos per replicate 
1 0 0 0.01 3 7 
2 10 0 0.01 3 7 
3 0 10 0.01 3 7 
4 0 100 0.01 3 7 
5 10 10 0.01 3 7 
6 10 100 0.01 3 7 
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2.3.4. Objective 4: The Influence of HPβCD on EE2 Toxicity 
2.3.4.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), was dissolved in acetone, and Hydroxypropyl-β-
cyclodextrin (HPβCD), 97.0 %, was purchased from Acros Oganics (New Jersey, USA) 
was dissolved in deionized water. Treatment solution were made using rearing solution as 
a diluent. Nominal treatments consisted of a carrier control, 10 ng/L EE2, 188 ng/L 
HPβCD, 10 ng/L EE2 + 47 ng/L HPβCD, 10 ng/L EE2 + 94 ng/L HPβCD, and 10 ng/L 
EE2 + 188 ng/L HPβCD. An acetone carrier concentration of 0.01 % v/v was maintained 
in each treatment. 
2.3.4.2. Experimental Procedure 
Embryonic Japanese medaka were obtained and maintained as described in section 
1.7.1.2. At 24 hpf, 12 embryos per treatment were exposed in a 6 well plate to a carrier 
control (0.01 % v/v acetone), 10 ng/L EE2, 188 ng/L HPβCD, 10 ng/L EE2 + 47 ng/L 
HPβCD, 10 ng/L EE2 + 94 ng/L HPβCD, and 10 ng/L EE2 + 188 ng/L HPβCD, with 10 
ml of treatment solution per well. At 48 hpf, embryos were thinned to 7 embryos per 
treatment (Table 7). 
Embryonic heart rate was monitored once every 24 hours beginning at 120 hpf and 
ending at hatch (192–216 hpf). Heart rate was determined by placing all 7 embryos from a 
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randomly selected single treatment on a petri dish. The embryos were acclimated for 2 
minutes before viewing under a Leica stereo microscope (Leica, Concord, Ontario, 
Canada). The number of heart beats that occurred in 20 seconds was determined and then 
converted to beats per minute by multiplying by three. The percent difference from the 
carrier control was calculated and used for analysis (Equation 1).  
Data were analyzed by calculating the mean heart rate in beats per minute for each 
treatment group and compared using an ANOVA. The data was not normally distributed, 
and a Kruskal-Wallis one way ANOVA on ranks test was completed. An all pairwise 
multiple comparison Tukey post hoc test was used to determine differences between 
treatments. All statistics were completed using Sigmaplot 13.0 (Statsoft, Inc. San Jose, 




Table 7: Exposure summary for Objective 4: The Influence of HPβCD on EE2 Toxicity. Nominal concentrations of 17α-ethinylestradiol 
(EE2), and hydroxypropyl-β-cyclodextrin (HPβCD) exposed to embryonic Japanese medaka (O. latipes), number of replicates, and 
number of embryos per replicate. 
Treatment # [EE2] (ng/L) [HPβCD] (ng/L) Acetone (%) Number of replicates  Number of embryos per replicate 
1 0 0 0.01 3 7 
2 10 0 0.01 3 7 
3 0 188 0.01 3 7 
4 10 47 0.01 3 7 
5 10 94 0.01 3 7 




2.4.1. Embryonic Heart Rate: EE2 and HPβCD – Pilot Studies 
Embryonic Japanese medaka were exposed to a range of EE2 concentrations in the 
initial pilot study. Temperature was monitored and maintained at 27.0 ± 0.5° C throughout 
all treatments. Mean heart rate, represented as percent change from the control, was 
assessed at 120 hpf. Control embryos had a mean heart rate of 100.0 beats per minute. 
Embryos exposed to 50, 500, and 5000 ng/L EE2 experienced a significant decrease in 
heart rate, 6.0, 6.6 and 5.4 % respectively, compared to the control (P ≤ 0.05) (Figure 2), 
while embryos exposed to 50000 ng/L EE2 experienced a 16.7 % increase in heart rate, 
which was significantly greater than the control (P ≤ 0.05) (Figure 2). 
For the range finding study, embryonic medaka were exposed to various 
concentrations of EE2, HPβCD, or a combination of EE2 and HPβCD. Temperature was 
monitored and maintained at 27.0 ± 0.5° C throughout all treatments. Heart rate was 
monitored every 24 h from 72 to 196 hpf, (Figure 3). At 72 hpf embryos exposed to EE2 
alone experienced a significant decrease in heart rate compared to the carrier control at 10 
ng/L, 100 ng/L, and 1000 ng/L EE2 in a concentration dependent manner (P ≤ 0.05) (Figure 
3A). The largest decrease in heart rate, -11.2 %, occurred at 1000 ng/L EE2. No significant 
differences were observed in embryos exposed to HPβCD compared to the carrier control 
alone at 72 hpf (P > 0.05) (Appendix: Figure S19). All combinations of EE2 and HPβCD 
treatments resulted in decreased heart rates in a concentration dependent manner  0.1 + 1.7 
ng/L, 1 + 17 ng/L, 10 + 170, 100 + 1700 ng/L, and 1000 + 17000 ng/L (EE2 + HPβCD) (P 
≤ 0.05) (Figure 3A). Embryos exposed to EE2 + HPβCD at 0.1 + 1.7 ng/L and 1 + 17 ng/L 
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treatments had significantly lower heart rates than embryos exposed to EE2 alone at 0.1 
ng/L and 1 ng/L (P ≤ 0.05) Figure 3A. 
A similar trend of decreasing heart rate was observed at 96 hpf. A reduced heart 
rate was observed in embryos exposed to 100 ng/L and 1000 ng/L EE2 alone compared to 
the carrier control (P ≤ 0.05) (Figure 3B). Embryos exposed to HPβCD experienced no 
significant difference compared to the carrier control (P > 0.05) (Figure S19). A reduced 
heart rate occurred in embryos exposed to 1 + 17 ng/L, 10 + 170 ng/L, 100 + 1700 ng/L, 
and 1000 + 17000 ng/L of EE2 + HPβCD compared to the carrier control (P ≤ 0.05) (Figure 
3B). Embryos exposed to EE2 + HPβCD at 1 + 1.7 ng/L had significantly lower heart rates 
than in embryos exposed to 0.1 ng/L EE2 alone (P ≤ 0.05). 
At 120 hpf, all EE2 alone treatment embryos had lower mean heart rates than the 
carrier control (P ≤ 0.05). The % decrease in heart rate ranged from 7.4 % at 0.1 ng/L EE2 
to 19.6 % and 18.5 % at 100 and 1000 ng/L EE2 respectively (Figure 3C). No significant 
difference compared to the carrier control was observed in embryos exposed to HPβCD (P 
> 0.05) (Appendix: Figure S19). The EE2 and HPβCD exposure resulted in reduced 
embryo heart rate at 0.1 + 1.7 ng/L, 1 + 17 ng/L, and 100 + 1700 ng/L EE2 + HPβCD 
treatments compared to the carrier control (P ≤ 0.05) (Figure 3C). The reduction in heart 
rate of embryos exposed to EE2 and HPβCD in combination was not concentration 
dependent and ranged from a decrease of 7.0 % at 0.1 + 1.7 ng/L EE2 and HPβCD to a 
decrease of 6.8 % at 100 + 1700 ng/L EE2 + HPβCD. Furthermore, no significant 
difference in embryo heart rate was observed at the highest concentration of 1000 + 17000 
ng/L EE2 + HPβCD. This trend differed from the EE2 alone exposure. Embryos exposed 
to EE2 alone had significantly reduced heart rates when compared to all EE2 + HPβCD 
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treatments with the exception of the 0.1 + 1.7 ng/L EE2 + HPβCD and 0.1 ng/L EE2 alone 
treatments (P ≤ 0.05). 
Similarly to 120 hpf, 144 hpf embryos exposed to EE2 experienced a significant 
decrease in heart rate at all exposure concentrations of 0.1 ng/L, 1 ng/L, 10 ng/L, 100 ng/L, 
and 1000 ng/L EE2 compared to the carrier control (P ≤ 0.05) (Figure 3D). A maximal 
response was observed at 100 ng/L EE2 with a 15.0 % decrease in heart rate. Embryos 
exposed to 17000 ng/L HPβCD alone experienced 5.7 % decrease in heart rate compared 
to the carrier control (P ≤ 0.05) (Appendix: Figure S19). No significant differences were 
observed in any EE2 + HPβCD treatment at 144 hpf (P > 0.05) (Figure 3B). In all 
treatments, embryos exposed to EE2 alone experienced greater reductions in heart rates 
when compared to EE2 + HPβCD treatments. 
Embryos observed at 168 hpf did not experience significant changes in heart rates 
in any treatments (P > 0.05) (Figure 3E). However, EE2 alone had a greater reduction in 
heart rate at 10 ng/L compared to the 10 + 170 ng/L EE2 +HPβCD. At 192 hpf no 
treatments were significantly different than the control (P > 0.05) (Figure 3F). However, 
EE2 + HPβCD exposures at 0.1 + 1.7 ng and 100 + 1700 ng/L EE2 + HPβCD resulted in 
greater reductions in embryo heart rates compared to the corresponding EE2 alone 







Figure 2: Pilot Study mean heart rate ± standard error (% change of control) of 120 hour 
post fertilization (hpf) embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2). Significant differences between treatments and control (0.01% 


















Figure 3: Range finding study mean heart rate ± standard error (% change of control) of embryonic Japanese medaka (O. latipes) exposed 
to 17α-ethinylestradiol (EE2) alone, or EE2 + hydroxypropyl-β-cyclodextrin (HPβCD). The heart rate of each embryo was assessed 
once every 24 hours at 72 (A), 96 (B), 120 (C): 144 (D), 168 (E), and (192) hours post fertilization (hpf). Significant differences between 
treatment and respective carrier controls (CC) (0.01% acetone) are represented by (*) (P ≤ 0.05), differences between EE2 alone and 
EE2 + HPβCD are represented by (    ∗    ) (P ≤ 0.05), Two-Way ANOVA, Dunnet’s post hoc n=15 embryos per treatment.
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2.4.2. EE2 Heart Rate Sex Comparison 
Male and female embryonic Japanese medaka were exposed to nominal treatment 
concentrations of 0.1 ng/L to 1000 ng/L EE2. Temperature was monitored and maintained 
at 27.0 ± 0.5° C throughout all treatments. The heart rate of each embryo was determined 
once every 24 h from 120 hpf to 216 hpf, and the mean % change from control (0.01 % 
acetone) was calculated (Figure 4). At 120 hpf, a significant decrease in mean embryonic 
heart rate was observed in male embryos exposed to 100 ng/L and 1000 ng/L EE2 
compared to the control (P ≤ 0.05) (Figure 4A). Female embryos experienced a significant 
decrease in heart rates relative to the control following exposure to 10 ng/L, 100 ng/L and 
1000 ng/L EE2 (P ≤ 0.05) (Figure 4A). Furthermore, mean female heart rates experienced 
a significantly greater decrease relative to the control than males at 10 ng/L EE2 during 
this time point (P ≤ 0.05) (Figure 4A). 
At 144 and 168 hpf, a significant decrease in mean embryonic heart rate was 
observed in all treatments of 0.1 ng/L, 1 ng/L, 10 ng/L, 100 ng/L, and 1000 ng/L EE2 for 
male and female Japanese medaka relative to the control (P ≤ 0.05) (Figure 4B, C). The 
decrease in heart rate appears to be concentration dependent at 168 hpf with 0.l ng/L and 
1000 ng/L EE2 resulting in nearly a 5% and 12 % decrease in heart rate respectively. There 
was no significant difference in mean male and female heart rates at these time points (P > 
0.05) (Figure 4B, C). 
The mean embryonic heart rate of male medaka significantly decreased in all 
treatment concentrations of 0.1 ng/L, 1 ng/L, 10 ng/L, 100 ng/L, and 1000 ng/L EE2 at 192 
hpf relative to the control (P ≤ 0.05) (Figure 4D). Female medaka experienced a significant 
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decrease in mean heart rate at 1 ng/L, 10 ng/L, 100 ng/L, and 1000 ng/L EE2 compared to 
the control (P ≤ 0.05) (Figure 4D). Mean male heart rates were significantly lower than 
females when exposed to 0.1 ng/L, 1 ng/L, and 100 ng/L (P ≤ 0.05) (Figure 4D). 
Measurements at 216 hpf showed a significant decrease in mean embryonic heart 
rates of both male and female medaka exposed to 0.1 ng/L, 100 ng/L, and 1000 ng/L EE2 
(P ≤ 0.05) Figure 4E. There were no significant differences between mean % change of 
















Figure 4: Mean heart rate ± standard error (% difference from control) of male and female embryonic Japanese medaka (O. latipes) 
exposed to 17α-ethinylestradiol (EE2) alone. The heart rate of each embryo was assessed once every 24 hours at 72 (A), 96 (B), 120 
(C): 144 (D), 168 (E), and (192) hours post fertilization (hpf). Significant differences between treatment and respective carrier controls 
(CC) (0.01% acetone) are represented by (*), differences between heart rate of male and female medaka are represented by (    ∗    ) (P 
≤ 0.05) Two-Way ANOVA, Dunnet’s post hoc. Each concentration was repeated three times with 7 embryos per concentration per sex. 
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2.4.3. ERα, ERβ, and GPER Agonists and Antagonists Impact on Embryonic 
Heart Rate 
Mixed sex Japanese medaka embryos were exposed to EE2 alone, or in 
combination with an agonist or antagonist for ERα ERβ, or GPER at 24 hours post 
fertilization, and heart rate was determined. Temperature was monitored and maintained at 
27.0 ± 0.5° C throughout all treatments. When embryonic medaka were exposed to 10 ng/L 
and 100 ng/L G-1, a GPER agonist, a significant decrease in mean heart rate was observed 
relative to the control at 120, 144, and 168 hpf (P ≤ 0.05) (Figure 5 and Figure S20). A 
similar decrease in heart rate was observed in medaka exposed to 10 ng/L EE2 at these 
time points (P ≤ 0.05). Exposure of medaka to EE2 and G-1 simultaneously caused a 
significant decrease in heart rate relative to the control (P ≤ 0.05), although it was not 
significantly different from embryos exposed to either EE2 alone or G-1 alone (P > 0.05) 
(Figure 5). At 192 hpf, only embryos exposed to 100 ng/L G-1 experienced a significant 
decrease in heart rate (P≤ 0.05) (Figure S20). 
Medaka embryos were exposed to Fulvestrant (ICI), a known GPER agonist and an 
ERα and ERβ antagonist, alone and in the presence of EE2. Temperature was monitored 
and maintained at 27.0 ± 0.5° C throughout all treatments. The mean heart rate of embryos 
exposed to 10 ng/L and 100 ng/L ICI both resulted in a significant decrease in heart rate at 
120, 144, and 168 hpf relative to the control (P ≤ 0.05) (Figure 6 and Figure S21). Similarly, 
exposure to 10 ng/L of EE2 resulted in a significant decrease in embryonic heart rates at 
all of these time points (P ≤ 0.05) (Figure 6 and Figure S21). At 120 hpf, exposure to EE2 
resulted in a decreased reduction in heart rate compared to ICI exposed embryos, however 
heart rate was still significantly lower than the control (P ≤ 0.05). No significant difference 
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was observed when comparing EE2 and ICI alone to the simultaneous exposure of EE2 
and ICI (P > 0.05) (Figure 6 and Figure S21). No observations at 192 hpf could be made 
due to a large proportion of hatched embryos at this time point. 
Embryonic heart rate was monitored following the exposure of medaka embryos to 
G-36, a GPER antagonist, alone and in combination with EE2. Temperature was monitored 
and maintained at 27.0 ± 0.5° C throughout all treatments. At time points 120, 144, and 
168 hpf, exposure to 10 ng/L of EE2 resulted in a significant decrease in heart rate (P ≤ 
0.05) (Figure 7 and Figure S22). There was no significant change in heart rate of embryos 
exposed to 10 ng/L and 100 ng/L of G-36 (P > 0.05) (Figure 7 and Figure S22). 
Additionally, embryos exposed to a combination of EE2 and G-36 experienced no change 
in heart rate relative to the control (P > 0.05) (Figure 7 and Figure S22). No significant 
change in heart rate from the control at 192 hpf occurred (P > 0.05) (Figure 7 and Figure 
S22). 
The heart rate of embryonic medaka was observed following exposure to PHTPP, 
an ERβ antagonist and EE2. Temperature was monitored and maintained at 27.0 ± 0.5° C 
throughout all treatments.  At 120, 144 and 168 hpf, a decrease in heart rate was observed 
in embryos exposed to 10 ng/L EE2 relative to the control (P ≤ 0.05) (Figure 8 and Figure 
S23). Conversely, at 120 and 144 hpf, heart rate of embryos exposed to 10 ng/L and 100 
ng/L PHTPP did not differ from the control (P > 0.05) (Figure 8 and Figure S23). At 168 
hpf exposures of 10 ng/L and 100 ng/L PHTPP resulted in a significant decrease in embryo 
heart rates compared to the control (P ≤ 0.05), but this effect was still significantly different 
from the EE2 alone treatment (P ≤ 0.05) (Figure 8 and Figure S23). At 120, 144 and 168 
hpf, embryos exposed to EE2 and PHTPP at the same time experienced a significant 
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decrease in hear rate relative to the control (P ≤ 0.05) (Figure 8 and Figure S23). Due to a 
large proportion of hatching, heart rate was unable to be determined at 192 hpf. 
Finally, embryonic medaka were exposed to an ERα antagonist, ZK 164015. 
Temperature was monitored and maintained at 27.0 ± 0.5° C throughout all treatments. At 
120, 144, 168 hpf a significant decrease in heart rate relative to the control was observed 
following exposure to 10 ng/L EE2 alone and when combined with ZK 164015 (P ≤ 0.05) 
(Figure 9 and Figure S24). The heart rate of embryos exposed to ZK 164015 alone did not 
differ from the control at these time points (P ≤ 0.05) (Figure 9 and Figure S24). No 








Figure 5: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, G-
1, a G Protein-Coupled estrogen receptor (GPER) agonist alone, or EE2 + G-1. Each 
treatment consists of three replicates containing 7 embryos per replicate. Significant 
differences from the control are represented by (*) (P≤0.05), ANOVA on Ranks (Kruskal-









Figure 6: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, 
Fulvestrant (ICI) (GPER agonist and ERα and ERβ antagonist) alone, or EE2 + ICI. Each 
treatment consists of three replicates containing 7 embryos per replicate. Significant 









Figure 7: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, G-
36 (GPER antagonist) alone, or EE2 + G-36. Each treatment consists of three replicates 
containing 7 embryos per replicate. Significant differences from the control are represented 









Figure 8: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, 
PHTPP (ERβ antagonist) alone, or EE2 + PHTPP. Each treatment consists of three 
replicates containing 7 embryos per replicate. Significant differences from the control are 









Figure 9: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, ZK 
164015 (ERα antagonist) alone, or EE2 + ZK 164015. Each treatment consists of three 
replicates containing 7 embryos per replicate. Significant difference from the control is 
represented by (*) (P≤0.05), ANOVA on Ranks (Kruskal-Wallis), Tukey post hoc.
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2.4.4. The Influence of HPβCD on EE2 Toxicity 
In order to understand the influence that HPβCD has on the embryo toxicity of EE2, 
mixture studies were conducted, and heart rate was assessed. Temperature was monitored 
and maintained at 27.0 ± 0.5° C throughout all treatments. As observed in previous 
sections, exposure of medaka embryos to EE2 alone resulted in decreased heart rates at 10 
ng/L at 120, 144 and 168 hpf (P ≤ 0.05) (Figure 10 and Figure S25). No significant 
differences were observed in the heart rate of medaka embryos exposed to 180 ng/L of 
HPβCD (P > 0.05) (Figure 10 and Figure S25). However, when EE2 was combined with 
HPβCD, a reduced effect was observed, meaning the heart rate became more similar to the 
control as the concentration of HPβCD increased. At 120, 144, and 168 hpf there were no 
significant differences in heart rates between the control and embryos exposed to 10 ng/L 
EE2 and 188 ng/L HPβCD , a 1:4 molar ratio (P ≤ 0.05) (Figure 10 and Figure S25). 
Furthermore, at 144 hpf there were no significant differences in embryo heart rates between 
the control and 10 ng/L EE2 + 94 ng/L HPβCD, a 1:2 molar ratio (P ≤ 0.05) (Figure 10). 










Figure 10: Mean heart rate ± standard error (% difference from control) of 144 hpf 
embryonic Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) alone, 
hydroxypropyl-β-cyclodextrin (HPβCD) alone, or EE2 + HPβCD in a 1:1 (10 ng/L + 47 
ng/L), 1:2 (10 ng/L + 94 ng/L), and 1:4 (10 ng/L + 188 ng/L) molar radio. Each treatment 
consists of three replicates containing 7 embryos per replicate. Significant difference from 





The environmental presence of pharmaceuticals and personal care products 
(PPCPs) has been an area of intrigue in the field of aquatic toxicology. Few PPCPs have 
been investigated as extensively as EE2, with many studies demonstrating high potency in 
non-target organisms (Parrott and Blunt, 2005; Kidd et al., 2007; Bhandari et al., 2015). 
This toxicity has often been related to ERα and ERβ activation, known as classical estrogen 
signaling, usually leading to feminization of males, and alterations in fertility and fecundity 
in fish (Jayasinghe and Volz, 2012; Prossnitz and Barton, 2014; Overturf et al., 2015; 
Romano et al., 2017). These effects have been demonstrated both in the laboratory and in 
whole lake systems (Parrott and Blunt, 2005; Kidd et al., 2007; Blanchfield et al., 2015). 
More recently, there has been a greater interest in non-classical estrogen signaling in non-
target organisms. This was aided by the discovery that estradiol (E2) is the ligand for the 
G protein-coupled estrogen receptor (GPER), formerly G protein receptor 30 (GPR30) 
(Jayasinghe and Volz, 2012; Romano et al., 2017). 
GPER is localized intracellularly on the membrane of the sarcoplasmic reticulum 
(Filardo and Thomas, 2012; Prossnitz and Barton, 2014; Barton, 2016; Sharma et al., 
2018). Expression of GPER (gper1) occurs throughout the body of vertebrates with higher 
levels found in the gonad, nervous system, and vasculature (Jayasinghe and Volz, 2012). 
Exposure of embryonic fish to estrogens and estrogen mimics has resulted in altered heart 
rates. Zebrafish (Danio rerio) embryos exposed to 1 mg/L estradiol (E2) experienced an 
increase in heart rate, tachycardia, while a decrease, bradycardia, was observed in 
embryonic zebrafish exposed to 0.4 ng/L 17α-ethinylestradiol (EE2) (Santos et al., 2014; 
Romano et al., 2017). Romano et al., (2017) demonstrated that GPER activation was 
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responsible for the increase in embryonic zebrafish heart rate. GPER activation presents a 
novel, non-classical, mode of action for EE2 toxicity in embryonic fish. 
A goal of this chapter was to determine how EE2 impacts heart rates of embryonic 
Japanese medaka at environmentally relevant concentrations. We also wanted to identify 
if the odour suppressant/excipient hydroxypropyl-β-cyclodextrin (HPβCD) could alter the 
observed toxicity of EE2. 
The first experiment in this chapter was completed to determine the general effect 
of EE2 on embryonic Japanese medaka heart rate. At 120 hours post fertilization (hpf), a 
decrease in heart rate was observed at 50 ng/L and an increase at 50000ng/L EE2 (Figure 
2). These bimodal results were consistent with the previous research where low and high 
concentrations of estrogenic compounds resulted in bradycardia and tachycardia, 
respectively (Santos et al., 2014; Romano et al., 2017). Furthermore, this demonstrated 
that the heart rate of FLFII Japanese medaka respond similarly to zebrafish, when exposed 
to EE2. It would be beneficial to further assess species differences in the future. The range 
finding study was conducted to identify the potential for HPβCD to alter this observed 
effect and establish a more accurate effective range for EE2 at environmentally relevant 
concentrations. It was decide to test lower concentrations of EE2, due to the observed effect 
at 5 ng/L in the pilot study and the to determine if we could replicate the effects observed 
by Santos et al., (2014). In this study, the most apparent effect was observed at 120 and 
144 hpf with a decrease was observed at 0.1 ng/L EE2 (Figure 3). This effect was mitigated 
by the presence of HPβCD, with the heart rate at control levels (Figure 3). These results 
provided justification for investigating the mode of action of EE2 and how HPβCD disrupts 
this toxicity at environmentally relevant concentrations. 
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The pilot study demonstrated that embryonic heart rate may be a valuable endpoint 
for monitoring EE2 toxicity in embryonic medaka. Based on previous research it was 
speculated that these effects were the result of GPER activation (Romano et al., 2017). 
Given that the natural ligand for GPER is E2, it was speculated that differential expression 
of gper in male and female embryos may occur. Since sex can be determined as early as 
72 hpf in female leucophore free (FLFII) medaka, it was decided that sex specific toxicity 
should be investigated prior to conducting other experiments. It was also unknown if the 
control heart rate differs between male female medaka embryos, which provided additional 
justification for this experiment. 
Following exposure, few differences in heart rate were observed between male and 
female embryonic heart rates, with the exception of the 192 hpf measurment (Figure 4). 
Moving forward from this study, embryos were exposed at 24 hpf rather than 6 hpf to 
ensure that there were a sufficient number of embryos in each replicate well. Unfertilized 
medaka embryos become blue in colour between 6 and 24 hpf when in rearing solution. 
Although some differences were observed between sexes at 192 hpf, both showed a similar 
response to EE2 exposure, and control heart rates were statistically similar. Thus, it was 
concluded that sexes did not require separation for future experimentation. Although 
separation by sex was not conducted in subsequent studies, future research in this area may 
be beneficial for explaining some of the variability observed, particularly when nearing 
hatch. The similarities in response were not surprising due to the expression of gper in 
many male tissues (Liu et al., 2009; Prossnitz and Barton, 2014). It has also been 
demonstrated that some gper mRNA is deposited into the embryo through maternal transfer 
(Jayasinghe and Volz, 2012). The presence of maternally transferred gepr mRNA may 
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offset any differential expression in males and females during embryo development. Sex 
dependent toxicity may become more apparent during life stages that are beyond 
embryogenesis; this was not studied in this thesis. It should be noted that the observed 
bradycardia appeared to be somewhat transient since the effect became less apparent as the 
embryos approached hatching (Figure 4). This may be indicative of the development of 
uptake/elimination as well as detoxification pathways (Hart, 1983; Iwamatsu, 2004; Kais 
et al., 2013). Uptake and elimination of EE2 during embryogenesis is examined in the 
following chapter. 
Although Romano et al., (2017) demonstrated that GPER activation was 
responsible for high concentration E2 induced tachycardia, the mode of action for low level 
EE2 induced bradycardia has not yet been elucidated. In this chapter, embryonic medaka 
were exposed to a series of estrogen receptor agonists and antagonists. G-1 was the first 
compound that was studied, a known selective GPER agonist in vertebrates. A similar 
response to EE2, decreased heart rate, was observed (Figure 5). This indicted that GPER 
activation can be, at least partly, responsible for the observed bradycardia. The next 
compound tested was Fulvestrant (ICI), a GPER agonist and an ERα and ERβ antagonist. 
The goal of this exposure was to further isolate GPER, while blocking EE2 activation of 
an ERα and ERβ. Comparable to G-1, ICI resulted in a similar response to EE2 alone 
(Figure 6). This experiment helped further demonstrate that GPER, not classical estrogen 
signaling, was responsible for the observed bradycardia. 
Next, we antagonized GPER with G-36, a known selective GPER antagonist. This 
exposure resulted in no change in heart rate from the control when alone or in combination 
with EE2 (Figure 7). This demonstrated that when GPER is antagonized, EE2 cannot 
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induce bradycardia in embryonic medaka. Finally, we examined PHTPP and ZK 164015, 
ERβ and ERα antagonists respectively. PHTPP alone at 120 and 144 hpf resulted in no 
change in heart rate (P > 0.05). However, at 168 hpf a decrease was observed relative to 
the control (P ≤ 0.05), this decrease was significantly less than EE2 alone (P ≤ 0.05). In 
both cases, PHTPP and ZK 164015 alone resulted in no change in heart rate, while 
exposure with EE2 resulted in a typical reduction of heart rate (Figure 8). This 
demonstrated that antagonizing ERα and ERβ individually had no impact on the ability of 
EE2 to cause reduced heart rate. In summary, these results are consistent with those of 
Romano et al. (2017). In their study, an increase was observed at 1 mg/L E2. The results 
found in our study demonstrate that the activation of GPER is responsible for the observed 
bradycardia in embryonic Japanese medaka. 
Localization of GPER and downstream signaling was investigated by Romano et 
al. (2017). They demonstrated that at high concentration of E2, GPER activation in the 
pituitary, upstream of triiodothyronine (T3) signaling can increase embryonic heart rate 
(Romano et al., 2017). Furthermore, tachycardia of gper mutants was rescued by T3 and 
not E2 (Romano et al., 2017). This indicates that T3 acts downstream of GPER in 
embryonic heart rate regulation. 
Given these results, there still exists the possibility that E2 could be altering 
intracellular calcium concentrations. Cytoplasmic calcium primarily originates from the 
sarcoplasmic reticulum within the cell (Evans et al., 2013; Vornanen, 2016). The G protein-
coupled estrogen receptor (GPER) is localized on the sarcoplasmic reticulum, and 
activation results in increased intracellular cellular calcium levels (Diamante et al., 2017). 
This could result in two additional potential mechanisms of action. Firstly, the membrane 
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could become more positive, thus increasing the plateau phase in ventricular myocyte 
depolarization, or in pacemaker cells such that rhythmic depolarization reaches the 
threshold of action potential more easily. Secondly, by occupying the TnC binding site on 
troponin, calcium allows myosin to bind to actin initiating the cross-bridge reaction, 
resulting in cardio myocyte contraction (Bers, 2008). Conversely, relaxation occurs when 
the membrane is repolarized and calcium returns to resting levels (Bers, 2008). Therefore, 
an increased intracellular calcium concentration could potentially lead to an extension of 
the contraction phase of cardiac myocytes; this may result in slowing the cardiac cycle, 
inducing bradycardia. This is a hypothesis that was not tested in our study, or the study by 
Romano et al., (2017). However, this potential mode of action may explain why different 
responses were observed at high concentration of E2 in the Romano et al., (2017) study, 
and at the low concentrations of EE2 in this, and the study conducted by Santos et al., 
(2017). 
The next experiment that was completed in this chapter examined the influence of 
HPβCD on the toxicity of EE2. Both EE2 and HPβCD are thought to exist together in 
surface water via municipal wastewater effluent. It has been previously noted that EE2 can 
be included, non-covalently, in the binding cavity of HPβCD (Pérez and Escandar, 2013). 
It has also been shown that HPβCD can suppress the estrogenic effects of E2 in a yeast 
two-hybrid assay (Oishi et al., 2008). HPβCD had no impact on E2 estrogen receptor 
affinity, suggesting that HPβCD may be blocking E2 from crossing biological membranes 
(Oishi et al., 2008). Given that GPER, like ERα and ERβ, is located inside the cellular 
membrane, the bulky, hydrophilic nature of HPβCD impedes EE2 from interacting with 
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GPER. In our study the additional barrier of the chorion must also be overcome to achieve 
receptor activation. 
We exposed medaka embryos across embryogenesis to 10 ng/L EE2 and a 1:1, 1:2, 
and 1:4 ratio of EE2:HPβCD. It has been shown that HPβCD has optimal guest inclusion 
at a ratio of 1:4 (Loftsson and Brewster, 2012). Our result demonstrated that at a 1:4 ratio 
of EE2:HPβCD resulted in a reduction of bradycardia in embryonic Japanese medaka when 
compared to EE2 exposed embryos (Figure 10). Furthermore, the heart rate of embryos 
exposed to 1:4 EE2:HPβCD were not statistically different from the control. A trend of 
lowered heart rate, relative to the control, was also observed as HPβCD concentrations 
were reduced. These results indicate that HPβCD may be interacting with EE2 and limiting 
its ability to interact with GPER. 
Overall, this chapter demonstrated that EE2 can induce bradycardia in embryonic 
Japanese medaka. It was also demonstrated that this is the result of GPER activation, non-
classical estrogen signaling. This is an important finding in the field of aquatic toxicology 
because it provides an additional mechanism of action for a very well-studied toxicant, 
EE2. Our results also demonstrated that HPβCD could reduce the effect of EE2 on 
embryonic Japanese medaka heart rate, highlighting a novel interaction in this field. The 
following chapters will investigate the uptake, elimination, and metabolic rate of embryos 







Chapter 3: Embryonic Uptake and Elimination of EE2, 
and the Influence of HPβCD
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3. Chapter 3: Embryonic Uptake and Elimination of EE2, and the Influence of HPβCD 
3.1. Introduction 
In Chapter 2, it was demonstrated that 17α-ethinylestradiol (EE2) could reduce the 
heart rate of embryonic Japanese medaka (Oryzias latipes) at environmentally relevant 
concentrations. These results were supported by Santos et al., 2014, exposing 0,4 ng/L of 
EE2 to embryonic zebrafish. It was also demonstrated that these effects were most likely 
due to the activation of the G protein-coupled estrogen receptor (GPER), a finding 
supported by the results of Romano et al., (2017). Decreased heart rate was observed in all 
treatments involving a GPER agonist at 120 and 144 hours post fertilization (hpf). 
However, as embryogenesis progressed, this effect often disappeared. The heart rate often 
returned back to control levels as hatching approached, while still in the presence of the 
agonist. This observation raised questions regarding the uptake and elimination of EE2 
from the embryo. The permeability of the chorion of fish has been known to increase as 
development progresses, but the elimination of certain contaminants during this time 
period is understudied (González-Doncel et al., 2004). Identifying the uptake and 
elimination of EE2 through the use of a radioisotope was thus one of the major goals of 
this research. 
Another important goal was to understand the effects of hydroxypropyl-β-
cyclodextrin (HPβCD) on EE2 uptake. Understanding the toxicity of mixtures has become 
increasingly important to aquatic toxicologists. Although the toxicity of multiple 
compounds can be extremely difficult to discern, it is extremely relevant when trying to 
replicate the complex mixtures found in wastewater. Mixtures involving HPβCD are very 
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intriguing due to its ability to chemically interact with guest compounds. In Chapter 2, it 
was demonstrated that in the presence of HPβCD, EE2 was no longer able to reduce the 
embryonic heart rate of Japanese medaka at 120 – 168 hpf. A hypothesis for this decreased 
toxicity is that HPβCD included EE2, increasing its bulkiness and inhibiting its ability to 
cross cellular membranes and potentially the chorion. If the HPβCD-EE2 complex was 
able to enter the chorion, it might still be impeded from being taken up by the developing 
embryo itself. Thus, the second major goal of this research was to identify the role of 
HPβCD in the uptake of EE2 into Japanese medaka embryos.
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3.2. Objectives, Knowledge Gaps, Rationale, and Hypotheses 
The overall goal of this chapter was to determine the uptake of 14C-EE2 in 
embryonic Japanese medaka in the presence and absence of HPβCD and to help answer 
two major questions. Firstly, how readily is EE2 taken up and eliminated by embryonic 
Japanese medaka and does uptake and elimination of EE2 occur uniformly across 
embryogenesis? Secondly, does HPβCD alter the uptake of EE2? This study was aimed at 
aiding in the understanding of how HPβCD may modify guest toxicity. Since HPβCD is 
thought to not readily cross biological membranes (Loftsson and Brewster, 2012), reduced 
EE2 uptake across the chorion may be the result of inclusion with HPβCD. 
3.2.1. Objective 1: 14C-EE2 Rangefinder Assay 
The goal of objective 1 was to determine a suitable exposure concentration range 
of 14C-EE2 such that the amount taken up by the embryo can be detected by the scintillation 
counter. This objective provided an appropriate exposure concentration of 14C-EE2 for the 
remaining objectives in this chapter. 
The null hypothesis for this experiment was: 
H0: The amount of 
14C-EE2 taken up by embryonic Japanese medaka exposed to 
14C-EE2 was not significantly different from the control group. 
3.2.2. Objective 2: 14C-EE2 Uptake and Elimination Assay 
Objective 2 was examined in order to determine uptake of 14C-EE2 throughout 
embryogenesis. It was observed in Chapter 2 that the effect of decreasing embryonic heart 
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rate appears to dissipate as the embryos approach hatch (192-216 hpf). This finding raised 
questions about the uptake and elimination of EE2 as embryogenesis progresses towards 
hatch. As development occurs, many physiological processes begin to initiate, including 
alterations in the permeability and elimination of toxicants from the embryo (González-
Doncel et al., 2004; Adams et al., 2005). This experiment examined various lengths of 
exposure and depuration following exposure to 14C-EE2. 
The null hypotheses for this experiment were: 
H0: The amount of 
14C-EE2 taken up by embryonic Japanese medaka was not 
significantly different than the control at any time point tested. 
H0: The amount of 
14C-EE2 taken up by embryonic Japanese medaka was not 
significantly different between any time points sampled. 
3.2.3. Objective 3: The Influence of HPβCD on the Uptake of 14C-EE2 
The null hypothesis for this experiment was: 
H0: The amount of 
14C-EE2 within Japanese medaka embryos exposed to 14C-EE2 
will not be different than those exposed to the carrier control (0.01 % acetone). 
H0: The amount of 
14C-EE2 within Japanese medaka embryos exposed to 14C-EE2 
will not be different than embryos exposed to 14C-EE2 + HPβCD. 
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3.3. Materials and Methods 
3.3.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
0.1mCi/ml 14C-EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol) in ethanol with 
a specific activity of 55 mCi/ml, was purchased from American Radiolabeled Chemicals, 
Inc. (St. Louis, Missouri, USA). Hydroxypropyl-β-cyclodextrin (HPβCD), 97.0 %, 
purchased from Acros Oganics (New Jersey, USA) was dissolved in deionized water. 
Treatment solution were made using rearing solution as a diluent. An acetone concentration 
of 0.01 % v/v was maintained in each treatment as a carrier and for consistency from 
previous experiments. 
3.3.2. Scintillation Counter and Calculations 
Determination of EE2 uptake was completed using a TriCarb Liquid Scintillation 
Analyzer (PerkinElmer, Waltham, Massachusetts, United States) and radiolabeled EE2 
(14C-EE2). The ionizing radiation from 14C-EE2 is detected by the scintillation counter by 
measuring the light pulses caused by the excitation of incident radiation in the scintillation 
fluid. This is reported in counts per minute and converted based on machine efficiency to 
disintegrations per minute (DPM) (Equation 2). DPM was then be converted to microcuries 
(µCi) (Equation 3). A blank consisting of scintillation fluid only was used and subtracted 
from the count. Next, µCi was converted to the number of moles of 14C-EE2 using the 
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specific activity of 14C-EE2 (Equation 4). Finally, the mass of 14C-EE2 was determined 







Equation 2: Conversion of counts per minute (CPM) to disintegrations per 
minute (DPM). Efficiency is calculated using a quench curve and 






Equation 3: Conversion of disintegrations per minute (DPM) to µCi, where 
x represents the number of µCi, and 2220000 is the number of 






Equation 4: Conversion of the number of µCi to moles, where i represents 
the number of moles, x represents the number of µCi determined in 
Equation 3, and y represents the specific activity of the radioisotope used. 
 




Equation 5: Conversion of moles to mass in grams, where α represents the 
mass in grams, i represents the number of moles determined in Equation 4, 
and 296.406 g/mol is the molar mass of EE2. 
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3.3.2.1. Instrument Calibration, Normalization, Performance Assessment, and 
Quench 
Calibration of the instrument ensures the photomultiplier tube response are 
synchronized to a Carbon-14 standard, resulting in accurate energy quantification of all 
beta particle emissions. Normalization establishes a numerical scale for sample quench. An 
unquenched Carbon-14 standard was counted and assigned a value of 1000 to the lowest 
allowable value for the Quench Indicating Parameter, tSIE (transformed Spectral Index of 
the External Standard). This allowed numerical values to be assigned to sampled quenches. 
Instrument performance assessment ensured that the instrument was operating within 
acceptable ranges of background counts, counting efficiency, sensitivity, and 
reproducibility. The background counts from the blank, containing scintillation fluid and 
dilution water, was subtracted from all sample counts (PerkinElmer, 2015). 
Calibration, normalization, and instrument performance assessment occurs 
automatically in the TriCarb Liquid Scintillation Analyzer (PerkinElmer, Waltham, 
Massachusetts, United States). A Self-Normalizing and Calibration (SNC) cassette, and an 
Instrument Performance Assessment (IPA) cassette from PerkinElmer (Waltham, 
Massachusetts, United States) were used. These cassettes remained on the counting deck 
at all times and contain a Carbon-14 calibration standard, an unquenched Tritium standard, 
and a background standard. Calibration, normalization and an instrument performance 
assessment was conducted prior to sample analysis unless it had been completed within the 
previous 23 hours (PerkinElmer, 2015). 
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A quench curve was used to correlate the sample counting efficiency of the 
instrument to a quench indicating parameter. Chemical and colour quench may occur, and 
can reduce counting efficiency of a sample due to the interference of production or 
detection of the photons produced when radioactive emissions interact with the scintillation 
solution. A quench standards assay was completed using quench standards from 
PerkinElmer (Waltham, Massachusetts, United States). The quench standards contain the 
same amount of nuclide with varying amounts of quenching agent, and the program 
QuantaSmart generated a quench curve to be stored it in the quench standards library. The 
quench curve was used to determine the counting efficiency of the instrument and 
calculated the disintegrations per minute (DPM) (Equation 2). 
3.3.3. Exposure Conditions 
Exposure of medaka embryos occurred in a fume hood within an approved 
radioisotope laboratory at the University of Ontario Institute of Technology (Oshawa, 
Ontario, Canada). The 6 well plates were placed on top of a heating pad in order to 
maintain similar temperatures (~27° C) to those achieved in previous experiments. The 
photoperiod was maintained at 16h light and 8 hours dark with a full spectrum LED 
lightbulb and an analogue timer. Solution changes and temperature monitoring occurred 
daily. 
3.3.4. Sample Analysis 
Sample detection occurred using a Tri-Carb 2800TR Liquid Scintillation Analyzer 
and analyses were completed using QuantaSmart software (PerkinElmer, Waltham, 
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Massachusetts, United States). After exposure to 14C-EE2, embryos were rinsed first with 
unlabeled EE2, and then rinsed 5 times with clean lab water to remove any 14C-EE2 that 
may have been residing on the outside of the chorion. All embryos from each replicate 
were then placed in 5 mL disposable scintillation vials containing 5 mL of Ultima Gold 
LCS Cocktail Sigma-Aldrich (Oakville, Ontario, Canada). All embryos per replicate were 
required to be pooled for analysis to achieve a strong enough signal for detection. Sample 
analysis occurred for 1 minute per sample, and the amount of 14C-EE2 was determined 
using Equation 2-5. 
3.3.5. Objective 1: Rangefinder Assay 
Embryonic Japanese medaka were obtained as described in section 1.7.1.2, and 
maintained as described in section 3.3.3. At 24 hpf, embryos were exposed to 10 mL of 0 
ng/L (Control), 100 ng/L, 1000 ng/L or 10000 ng/L 14C-EE2 in a 6 well plate Each 
treatment was repeated 3 times with 40 embryos per replicate, (Table 8) and at 120 hpf, the 






Table 8: Exposure summary for Objective 1: Rangefinder Assay. Concentrations of 14C-
17α-ethinylestradiol (14C-EE2), which embryonic Japanese medaka (O. latipes) were 
exposed to, the number of embryos per treatment, and the number of replicates.
[14C-EE2] (ng/L) Number of Embryos Replicates 
0 – Control 40 1 
100 40 1 
1000 40 1 
10000 40 1 
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3.3.6. Objective 2: EE2 Uptake and Elimination Assays 
3.3.6.1. Uptake 
Embryonic Japanese medaka were obtained as described in section 1.7.1.2, and 
maintained as described in section 3.3.3. For the continuous exposure study, 60 embryos 
per replicate were used rather than 40 to ensure a strong enough signal in the scintillation 
counter. Embryos were exposed to 10 mL of 10 µg/L 14C-EE2 in a 6 well plate for varying 
lengths of time. All exposures began at 6 hpf, and sampling occurred at 24, 48, 96, and 168 
hpf (Table 9). Sampling was conducted as described in section 3.3.4 above. A non-linear 
regression and an ANOVA with a Tukey post hoc test were completed using Sigmaplot 
13.0 (Statsoft, Inc. San Jose, USA). 
Embryonic Japanese medaka were obtained as described in section 1.7.1.2, and 
maintained as described in section 3.3.3. For the pulse exposure study, embryos were 
exposed to 10 mL of 10 µg/L ng/L 14C-EE2 in a 6 well plate for 24 hours. All exposures 
began at 6, 24, 48, 72, 96, 120, or 144 hpf, and were sampled 24 hours after exposure began 
as described in section 3.3.4 above. Three replicates per exposure window and 60 embryos 
per replicate were used (Table 10). A non-linear regression and an ANOVA with a Tukey 




Table 9: Exposure duration of Japanese medaka (O. latipes) to 14C-EE2, Objective 2: Uptake, continuous exposure. The darkened line 
 represents the time of exposure to 10 µg/L 14C-EE2, and “Sampled” denotes the time point when the embryos were analyzed in 
hours post fertilization (hpf). 
 Hours Post Fertilization (hpf) 
Test # 6 24 48 72 96 120 144 168 
1  Sampled       
2   Sampled      
3     Sampled    




Table 10: Exposure duration of Japanese medaka (O. latipes) to 14C-EE2, Objective 2: Uptake, pulse exposure study. The darkened line  
 represents the time period of pulse exposure to 10 µg/L 14C-EE2, and “Sampled” denotes the time point when the embryos were 
analyzed in hours post fertilization (hpf). 
 Hours Post Fertilization (hpf) 
Test # 6 24 48 72 96 120 144 168 
1  Sampled       
2   Sampled      
3    Sampled     
4     Sampled    
5      Sampled   
6       Sampled  




Embryonic Japanese medaka were obtained as described in section 1.7.1.2, and 
maintained as described in section 3.3.3. For the elimination study, embryos were exposed 
to 10 mL of 10 µg/L ng/L 14C-EE2 in a 6 well plate from 6 – 48 hpf. The amount of 14C-
EE2 per embryo was then assessed as described in section 3.3.4, at 0, 24, 48, 96, and 120 
hours after returning to clean water (Table 11). Three replicates containing 60 embryos per 
replicate were completed. A non-linear regression and an ANOVA with a Tukey post hoc 




Table 11: Exposure duration of Japanese medaka (O. latipes) to 14C-EE2, Objective 2: Depuration study. The darkened line  
represents the time of exposure to 10 µg/L 14C-EE2, and “Sampled” denotes the time point when the embryos were analyzed in hours 
post exposure. 
 Hours Post Fertilization (hpf) Hours Post Exposure  
Test # 6 24 48 0 24 48 72 96 120 
1   
 
Sampled      
2   
 
 Sampled     
3   
 
  Sampled    
4   
 
   Sampled   
5   
 
    Sampled  
6   
 
     Sampled 
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3.3.7. Objective 3: The Influence of HPβCD on the Uptake of EE2 
Embryonic Japanese medaka were obtained as described in section 1.7.1.2, and 
maintained as described in section 3.3.3 At 120 hpf, 60 embryos per replicate were exposed 
to 10µg/L 14C-EE2 alone, and to a mixture of 188 µg/L HPβCD and 10 µg/L 14C-EE2. 
After 24 hours of exposure at 144 hpf, all treatments were assessed as described in section 
3.3.4. A Student’s T-test was conducted to compare the means to the two groups using 




3.4.1. Objective 1: 14C-EE2 Rangefinder Assay 
In the rangefinder experiment, 40 medaka embryos were exposed to 100 ng/L, 1000 
ng/L and 10000 ng/L 14C-EE2 from 24 hpf to 120 hpf. Uptake was determined to be 112.0 
ng, 415.0 ng, and 665.6 ng of 14C-EE2 per embryo (Table S14). This data was used to 
justify a concentration of 10 µg/L 14C-EE2 and 60 embryos per replicate for the following 
studies. 
3.4.2. Objective 2: 14C-EE2 Uptake and Elimination Assays 
Embryonic uptake was assessed following a continual exposure to 14C-EE2 for 
varying lengths of time. All exposures began at 6 hpf and were terminated at 24, 48, 96, 
and 168 hpf. A very strong positive sigmoidal correlation was observed and described by 
the equation y=(1451.6818)/1+exp(-(x-85.1238)/23.7694)) with an r2 value of 0.9999 
(Figure 11). Uptake in embryonic medaka appeared to be reaching a plateau at 168 hpf, 
with approximately 1400 ng of 14C-EE2 per embryo. A significant difference in 14C-EE2 
uptake was observed between all exposure time points (P ≤ 0.05). 
The uptake of 14C-EE2 over a 24 hour period was determined across 
embryogenesis. Exposures began at 6, 24, 48, 72, 96, 120, and 144 hpf, and sampling 
occurred 24 h after the initiation of exposure. A strong positive quadratic correlation was 
observed when comparing embryonic age that can be described by the equation 
y=121.5052+(-0.9265)x+(0.0114)x with an r2 value of 0.9350 (Figure 12). A notable point 
on the curve occurred when embryos were exposed at 6 hpf, where their mean uptake was 
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greater than the next age of exposure, 24 hpf, although not statistically significant (P>0.05). 
After this temporary decrease, the uptake of 14C-EE2 continued on an upward trajectory 
(Figure 12). Uptake of 14C-EE2 was significantly greater in embryos exposed from 144 to 
168 hpf, compared to all other exposure windows (P ≤ 0.05). Embryos exposed from 120 
to 144 hpf also experienced significantly greater 14C-EE2 uptake than 6 – 30, 24 – 48 and 
48 – 72 hpf exposures (P ≤ 0.05). 
Elimination of 14C-EE2 was assessed in Japanese medaka embryos every 24 hours 
following exposure from 6 – 48 hpf. At 0 hours post exposure, an average of 360 ng of 14C-
EE2 was taken up per embryo, and at 120 hours post exposure, this was reduced to an 
average of 165 ng of 14C-EE2 per embryo. Elimination of 14C-EE2 was characterized by a 
three parameter exponential decay equation (y=139.5332+223.2979(exp(-0.0236(x))) with 
an r2 value of 0.9624 as a function of time (Figure 13). A significant decrease in the amount 
of 14C-EE2 within each embryo was observed in all time points when compared to 0 hours 
post exposure (P ≤ 0.05). Embryos from 48, 72, 96 and 120 hours post fertilization all 
contained significantly lower amounts of 14C-EE2 when compared to 24 hours post 
exposure embryos. (P ≤ 0.05). No significant differences were observed between 72, 96, 







Figure 11: Mean mass ± standard error of 14C-17α-ethinylestradiol (14C-EE2) per Japanese 
medaka (O. latipes) embryo following a continuous exposure to 10 µg/L 14C-EE2 6 – 30 
hours post fertilization (hpf), 6 – 48 hpf, 6 – 96 hpf, and 6 – 168 hpf. All embryos were 
sampled at the end of the exposure window. Three replicates per time point with 60 
embryos per replicate were tested. An equation of y=(1451.6818)/1+exp(-(x-







Figure 12: Mean mass ± standard error of 14C-17α-ethinylestradiol (14C-EE2) per Japanese 
medaka (O. latipes) embryo following a 24 hour pulse exposure to 10 µg/L 14C-EE2 6 – 
30 hours post fertilization (hpf), 24 – 48 hpf, 48 – 72 hpf, 72 – 96 hpf, 96 – 120 hpf, 120 – 
144 hpf, and 144 – 168 hpf. All embryos were sampled at the end of the exposure window. 
Three replicates per time point with 60 embryos per replicate were tested. An equation of 







Figure 13: Mean mass ± standard error of 14C-17α-ethinylestradiol (14C-EE2) per Japanese 
medaka (O. latipes) embryo following an exposure to 10 µg/L 14C-EE2 from 6 – 48 hours 
post fertilization (hpf). Following exposure embryos were placed in rearing solution and 
sampled at 0, 24, 48, 72, 96 and 120 hours post exposure. Embryo age, in hours post 
fertilization (hpf), is also indicated on the figure. Three replicates per time point with 60 
embryos per replicate were tested. An equation of y=139.5332+223.2979(exp(-0.0236(x))) 
was generated with r2=0.9624.
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3.4.3. Objective 3: The Influence of HPβCD on the Uptake of 14C-EE2 
The role of HPβCD in the uptake of 14C-EE2 into the chorion of 120 hpf embryonic 
Japanese medaka was assessed. The mass of 14C-EE2 was determined following a 24 hour 
exposure to 10 µg/L 14C-EE2 in the presence and absence of 188 µg/L HPβCD from 120 
hpf to 144 hpf. The results demonstrated no significant difference in the mass of 14C-EE2 








Figure 14: Mean mass  ± standard error of 14C-17α-ethinylestradiol (14C-EE2) per Japanese 
medaka (O. latipes) embryo following a 24 hour pulse exposure to 10 µg/L 14C-EE2 and 
10 µg/L 14C-EE2 + 188 µg/L (1:4 molar ratio) hydroxypropyl-β-cyclodextrin (HPβCD) 
from 120 – 144 hours post fertilization (hpf). All embryos were sampled at the end of the 
exposure window. Three replicates per time point with 60 embryos per replicate were 





A common assumption when assessing toxicity is a toxicants ability to interact, in 
some way, with a target site. This can be particularly challenging when studying embryo 
toxicity, as the chorion is an acellular envelope that separates developing embryos from 
the surrounding environment and thus can act as an additional biological barrier(Hart, 
1983). In addition to chorion permeability, toxicity assessment during embryogenesis can 
be uniquely challenging due to the rapid developmental changes that occur in this phase. 
Toxicity is often transient or delayed depending on organ development, metabolism, and 
the presence of target sites. Currently, few studies have examined the uptake and 
elimination of PPCPs in embryonic fish. In this chapter, we examined the uptake and 
elimination of 17α-ethinylestradiol (EE2) across Japanese medaka (Orizias latipes) 
chorions at various stages of embryonic development. This was of particular interest given 
the observed transient effect of EE2 on embryonic heart rate observed in Chapter 2. It was 
also observed in Chapter 2 that hydroxypropyl-β-cyclodextrin (HPβCD) impeded this toxic 
effect of EE2. It was hypothesized that uptake of EE2 may have been reduced due to 
inclusion into the relatively large HPβCD molecule, ~1.4 kDa. The general aims of this 
chapter was to further understand the uptake and elimination of EE2 at various stages of 
development, and in the presence and absence of HPβCD from 120 – 144 hpf. 
The first study in this chapter examined the uptake at following continuous 
exposure to radiolabeled 10µg/L EE2 (14C-EE2) at various stages of embryonic 
development. It was observed that as the length of exposure increased across 
embryogenesis, the amount of 14C-EE2 increased in a sigmoidal fashion (Figure 11). 
Maximal uptake was approached at 168 hpf with approximately 1400 ng of 14C-EE2 per 
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embryo; further assessment was not possible due to hatching beyond this time point. This 
demonstrated that 14C-EE2 is able to cross the chorion of embryonic medaka. Furthermore, 
it showed that uptake of 14C-EE2 increases to a plateau when nearing hatch. Next, uptake 
was examined during 24 hour exposure windows across embryogenesis. A similar response 
was observed, with uptake increasing exponentially as embryogenesis progressed (Figure 
12), indicating that permeability also increases dramatically as development progresses. 
This is supported by the observation that the chorion of fish becomes more permeable as 
embryogenesis progresses due to increasing size of chorion pore canals, and the breakdown 
of the chorion at stage 34, 120 hpf (Rubstov, 1981; González-Doncel et al., 2004; Adams 
et al., 2005).  
Uptake in this manner was expected since EE2 is a small lipophilic compound. This 
result is supported by observations of estradiol (E2) uptake in zebrafish (Danio rerio), 
where chorion permeability increased with the age of the embryo (Souder and Gorelick, 
2017). Additionally, little difference in uptake was observed in intact embryos versus intact 
embryo exposure followed by manual chorion removal (Souder and Gorelick, 2017), 
providing additional evidence that E2 is taken up across the chorion and into the developing 
embryo. Given the chemical similarities, it is expected that EE2 would behave in the same 
way as E2 (Table 2). In another study exposing embryonic medaka to radiolabeled EE2, 
EE2 was also taken up across the chorion (Bhandari et al., 2015). When compared to the 
findings in Chapter 2, this result is consistent with a greater response as time progressed, 
until approximately 144 -168 hpf. These results became somewhat contradictory as 
hatching approached, indicating that another mechanism such as detoxification could have 
been initiated at this time point (Figure 3 and Figure 4). 
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The third study in this chapter looked at elimination of EE2 in embryonic medaka 
in an attempt to elucidate the cause of the observed transient toxicity of EE2. Given that 
the absolute amount of 14C-EE2 continued to increase with time during exposure, 
elimination was not a leading hypothesis. Nonetheless, we felt it was important to 
investigate this endpoint to gain a better understanding of EE2 interaction with the embryo. 
It was observed that elimination of EE2 occurred in an exponential decay manner (Figure 
13). As time progressed, the rate of EE2 elimination slowed, indicating that after 120 hours 
of depuration at 168 hpf, some amount of EE2 remained within the embryo. This was 
expected given the lipophilic nature of EE2. It has also been reported that E2 can be taken 
up by the yolk, indicating a potential location for EE2 sequestration (Souder and Gorelick, 
2017). 
Although uptake and elimination of 14C-EE2 did not provide plausible evidence for 
the observed transient effect, detoxification may still be occurring. A major limitation of 
using radiolabeled isotopes in toxicological work is that it only reports the absolute amount 
of 14C present in a sample. Therefore, it does not take into consideration metabolism of the 
parent drug into inactive or metabolized forms. This is a potential area of future research, 
which would aid in explaining the observed transient effects in this study as well as 
defining when metabolism becomes active in embryonic fish. 
The last portion of this chapter looked into the effects of HPβCD on EE2 uptake. 
As described in Chapter 2, HPβCD appears to reduce the effect of EE2 on embryonic heart 
rates with the exception of exposure at 72 and 96 hpf. A potential explanation of this result 
was that HPβCD reduces EE2 uptake across the chorion. However, our results showed no 
change in EE2 uptake across the chorion during a 24 hour exposure from 120 – 144 hpf 
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(Figure 14). These results were somewhat expected given the size of HPβCD, ~1.4 kDa, 
and the diameter of chorion pore canals, 3-4 kDa. Although these results did not support 
our hypothesis, uptake into the developing embryo and within the cells could still be 
hindered by HPβCD. Future research into uptake beyond the chorion should be 
investigated since HPβCD is thought to have difficulty crossing cellular membranes due to 
size and hydrophilicity limiting the ability for EE2 to interact with GPER (Oishi et al., 
2008). Exposing intact embryos to 14C-EE2 + HPβCD, followed by manual chorion 
removal and then quantifying 14C-EE2 uptake within the embryonic fish could potentially 
address this question. Furthermore, assessment of 14C-EE2 uptake in the presence of 
HPβCD at various time points should be determined due to the reported initiation of 
chorion breakdown at 120 hpf in Japanese medaka (González-Doncel et al., 2004). 
In summary, this chapter identified that EE2 was readily taken up by embryonic 
Japanese medaka, further supporting the susceptibility of fish embryos to EE2. Although 
identification of how HPβCD impedes EE2 toxicity was not determined, future research 











4. Chapter 4: The impact of EE2 on Embryonic Oxygen Consumption (MO2) 
4.1. Introduction 
The use of apical endpoints such as growth, reproduction, and metabolism aid in 
the understanding of how a particular toxicant may impact the overall fitness of an 
organism. When trying to relate laboratory findings to more relevant higher levels of 
biological organization such as population effects, these apical endpoints are critical. When 
using sub-apical endpoints such as heart rate or gene transcription, it is thus advantageous 
to relate these observed effects with corresponding apical endpoints. Although sub-apical 
endpoints often help elucidate a mode of action or identify a molecular initiating event, the 
linkage to an apical endpoint is not always clear (Miracle and Ankley, 2005). 
Understanding this is very important when conducting ecological risk assessments 
(Miracle and Ankley, 2005; Ankley et al., 2010). Thus, the effects of EE2 on embryonic 
metabolic rate was examined in this chapter to see if there was a link to the observed EE2 
induced effects on heart rate (Chapter 2). The benefits of assessing heart rate rather than 
MO2, is due to ease of measurement, lower associated costs, and minimal specialized 
equipment. However, MO2 is a more direct measure of metabolism, and is commonly 
measured using a swim tunnel or microplate respirometers. Alterations in MO2 can limit 
the fitness of a fish within an ecosystem. For example, decreases in MO2 have been known 
to slow growth, and impede the energetics of an organism (Houde and Schekter, 1983). 
Since most fish are ectotherms, water temperature is an important modifying factor of 
metabolic rate, and thus must be controlled for (Vornanen, 2016). 
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The Fick principle describes the relationship between metabolic rate and heart rate, 
in terms of oxygen consumption, (Equation 6) (Priede and Tytler, 1977). This principle has 
been applied with success to birds and mammals, however, its relation to fish appears to 
be less direct. It was demonstrated in rainbow trout (Oncorhynchus mykiss) that changes 
in oxygen demands were achieved by adjusting stroke volume with minor changes in heart 
rate (Stevens and Randall, 1967). This suggested that heart rate may not be the best measure 
of metabolism in fish. However, a study by Folkerts et al., (2017), demonstrated that 
hydraulic fracturing flow-back and produce water caused a decrease in larval zebrafish 
heart rate. They supported this finding by using a Loligo® Microplate respirometer which 
showed a decrease in MO2. 
 
𝑀𝑅 = 𝐻𝑅 × 𝑆𝑡𝑟𝑜𝑘𝑒 𝑉𝑜𝑙𝑢𝑚𝑒 ×  (𝐴 − 𝑉 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒) 
Equation 6: The Fick principle, where MR represents metabolic rate, HR 
represents heart rate, the stroke volume is the volume of one heart beat, and 
the A – V difference is the difference in oxygen content of arterial and 
venous blood (Priede and Tytler, 1977). 
 
A major goal of this chapter was to determine if there is a link between the EE2 
induced heart rate reduction and MO2 in embryonic Japanese medaka (Oryzias latipes). As 
with Chapters 2 and 3, we wanted to also determine if hydroxypropyl-β-cyclodextrin 
(HPβCD) had the ability to alter any potential EE2 induced MO2 changes. We hypothesized 
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that HPβCD will lessen the effects of EE2 given that we have previously demonstrated 




4.2. Objectives, Knowledge Gaps, Rationale, and Hypotheses 
4.2.1. Objective 1: EE2 and Embryonic MO2 
The first objective of this chapter was to provide physiological relevancy to the 
alterations in embryonic heart rate that was observed in Chapter 2. We thus investigated if 
EE2 exposure altered the MO2 of embryonic Japanese medaka. To the best of our 
knowledge, no research has been previously published on the impacts of EE2 on the MO2 
of embryonic fish. 
The null hypothesis for this experiment was: 
H0: There are no differences in the oxygen consumption rate (MO2) between 
embryonic Japanese medaka exposed to EE2 and the carrier control (0.01 % v/v acetone). 
4.2.2. Objective 2: Impact of EE2 and HPβCD on Embryonic MO2 
The second objective was to determine if the effects of EE2 on embryonic MO2 
could be altered by the presence of HPβCD. In Chapter 2, it was demonstrated that HPβCD 
mitigated the effects of EE2. The aim in this chapter was to identify if this reduction in 
toxicity could be observed on MO2, providing direct physiological relevancy. 
The null hypothesis for this experiment was: 
H0: There are no differences in the oxygen consumption rate (MO2) between 




4.3. Materials and Methods 
4.3.1. Objective 1: EE2 and Embryonic MO2 
4.3.1.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), was dissolved in acetone. EE2 treatments were made 
through serial dilutions with rearing solution as the diluent, providing for final nominal 
exposure concentrations of 0 ng/L (carrier control), 1 ng/L, 10 ng/L, 100 ng/L, 1000 ng/L, 
and 10 000 ng/L EE2. All treatments had an acetone concentration of 0.01 % v/v. 
4.3.1.2. Experimental Procedure 
Embryonic Japanese medaka were obtained and maintained as described in section 
1.7.1.2. At 24 hpf, 5 embryos per treatment were exposed in a 24 well plate to a carrier 
control (0.01 % v/v acetone), 1 ng/L, 10 ng/L, 100 ng/L, 1000 ng/L, and 10 000 ng/L EE2, 
with 2 ml of treatment solution per well with 6 replicates per treatment. All solutions were 
renewed daily, and at 48 hpf, embryos were thinned to 3 embryos per replicate (Table 12). 
Exposure and MO2 measurements were conducted in a 27° C temperature control room. 
Embryonic oxygen consumption rate (MO2) was monitored at 120 and 144 hpf with a 24 
well Loligo® Systems Microplate respirometer (Viborg, Denmark). During measurement, 
three embryos from each replicate were transferred from the 24 well exposure plate into 
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the wells of the respirometer, with 6 blank wells filled with control solution and containing 
no embryos. The wells were filled to the top with the corresponding treatment solution, 
minimizing headspace. The respirometer was sealed with Parafilm from Bemis North 
America (Neenah, Wisconsin, USA), a weighted block supplied by Loligo® Systems 
(Viborg, Denmark) was placed on top to aid in sealing. The plate was then placed on the 
reader. Readings occurred on a plate shaker set to 60 rpm and MO2 was monitored for 30 
minutes. After the reading was complete, the embryos were returned to their original 24 
well exposure plate. The same embryos were sampled at 120 and 144 hpf. 
Data was analyzed by calculating mean oxygen consumption (pmol/min) for each 
treatment group. After testing for normality and homogeneity, an ANOVA with a Dunnet’s 
post hoc test was used to determine a difference between treatments and the control. All 
statistics were completed using Sigmaplot 13.0 (Statsoft, Inc. San Jose, USA) and run at an 




Table 12: Exposure summary for EE2 impact on metabolic rate of embryonic Japanese medaka (O. latipes). Nominal exposure 
concentrations of 17α-ethinylestradiol (EE2), number of replicates, and number of embryos per replicate are listed. 
Treatment # [EE2] (ng/L) Acetone (%) Number of replicates  Number of embryos per replicate 
1 0 0.01 6 3 
2 1 0.01 6 3 
3 10 0.01 6 3 
4 100 0.01 6 3 
5 1000 0.01 6 3 
6 10000 0.01 6 3 
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4.3.2. Objective 2: Impact of EE2 and HPβCD on Embryonic MO2 
4.3.2.1. Chemicals 
Rearing solution was made in house and comprised of 10 % NaCl, 0.30 % KCl, 
0.40 % CaCl2·2H2O, 1.63 % MgSO4·7H2O, 0.01 % methylene blue, and distilled water. 
EE2 (19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3, 17-diol), purchased from Sigma-
Aldrich (Oakville, Ontario, Canada), was dissolved in acetone, and Hydroxypropyl-β-
cyclodextrin (HPβCD), 97.0 %, was purchased from Acros Oganics (New Jersey, USA) 
was dissolved in deionized water. Treatment solutions were made using rearing solution as 
a diluent. Nominal treatments consisted of a carrier control, 10 ng/L EE2, 188 ng/L 
HPβCD, 10 ng/L EE2 + 47 ng/L HPβCD, 10 ng/L EE2 + 94 ng/L HPβCD, and 10 ng/L 
EE2 + 188 ng/L HPβCD. An acetone concentration of 0.01 % v/v was maintained in each 
treatment. 
4.4. Experimental Procedure 
Embryonic Japanese medaka were obtained and maintained as described in section 
1.7.1.2. At 24 hpf, 5 embryos per treatment were exposed in a 24 well plate to a carrier 
control (0.01 % v/v acetone), 10 ng/L EE2, 188 ng/L HPβCD, 10 ng/L EE2 + 47 ng/L 
HPβCD, 10 ng/L EE2 + 94 ng/L HPβCD, and 10 ng/L EE2 + 188 ng/L HPβCD, with 2 ml 
of treatment solution per well with 6 replicates per treatment. All solutions were renewed 
daily and at 48 hpf embryos were thinned to 3 embryos per treatment (Table 13). Exposure 
and MO2 measurements were conducted in a 27° C temperature control room. 
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Embryonic oxygen consumption rate (MO2) was monitored at 120 and 144 hpf with 
a 24 well Loligo® Systems Microplate respirometer (Viborg, Denmark). During oxygen 
consumption measurement, three embryos from each treatment were transferred from the 
24 well exposure plate into the wells of the respirometer, with 6 blank wells filled with 
control solution and containing no embryos. The wells were filled to the top with the 
corresponding treatment solution, minimizing headspace. The respirometer was sealed 
with Parafilm from Bemis North America (Neenah, Wisconsin, USA), a weighted block 
supplied by Loligo® Systems (Viborg, Denmark) was placed on top to aid in sealing. The 
plate was then placed on the reader. Readings occurred on a plate shaker set to 60 rpm as 
per the manufacturer’s instructions. MO2 was monitored for 30 minutes. After the reading 
was complete, the embryos were returned to their original 24 well exposure plate. 
Data were analyzed by calculating mean oxygen consumption (pmol/min) for each 
treatment group. After testing for normality and homogeneity, an ANOVA with a Tukey 
post hoc test was used to determine a difference between treatments. All statistics were 




Table 13: Exposure summary for EE2 impact on metabolic rate of embryonic Japanese medaka (O. latipes). Nominal concentrations of 
17α-ethinylestradiol (EE2) and hydroxypropyl-β-cyclodextrin (HPβCD), number of replicates, and number of embryos per replicate are 
listed. 
Treatment # [EE2] (ng/L) HPβCD (ng/L) Acetone (%) Number of replicates  Number of embryos per replicate 
1 0 0 0.01 6 3 
2 10 0 0.01 6 3 
3 0 188 0.01 6 3 
4 10 47 0.01 6 3 
5 10 94 0.01 6 3 





4.5.1. Objective 1: EE2 and Embryonic MO2 
Oxygen consumption (MO2) of embryonic Japanese medaka was assessed at 120 
and 144 hpf following exposure to a range of EE2 concentrations. At 120 hpf, a mean MO2 
of 74.7 pmol/min was observed (Figure 15). This was significantly greater than embryos 
exposed to 1 ng/L EE2, which had a mean of 47.2 pmol/min (P ≤ 0.05) (Figure 15). 
Exposure to 10, 100, 1000, and 10000 ng/L EE2 resulted in no significant change from 
control (P > 0.05). 
At 144 hpf, the MO2 of control embryos was 81.6 pmol/min (Figure 16). No 
significant differences in MO2 were observed in any of the EE2 exposures when compared 
to the control (P > 0.05). However, a trend of increasing MO2 with an increasing EE2 
concentration was observed, with the lowest MO2, 56.97 pmol/min occurring at 1 ng/L 







Figure 15: Mean oxygen consumption (MO2) ± standard error per embryo of 120 hour post 
fertilization (hpf) Japanese medaka (O. latipes) exposed to 0 (carrier control, 0.01 % v/v 
acetone) 1, 10, 100, 1000, and 10000 ng/L 17α-ethinylestradiol (EE2). Each treatment 
consists of six replicates containing 3 embryos per replicate. Significant difference from 







Figure 16: Mean oxygen consumption (MO2) ± standard error per embryo of 144 hour post 
fertilization (hpf) Japanese medaka (O. latipes) exposed to 0 (carrier control, 0.01 % v/v 
acetone) 1, 10, 100, 1000, and 10000 ng/L 17α-ethinylestradiol (EE2). Each treatment 
consists of six replicates containing 3 embryos per replicate. Significant difference from 
the control is represented by (*) (P ≤ 0.0.5), ANOVA.
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4.5.2. Objective 2: Impact of EE2 and HPβCD on Embryonic MO2 
The mean MO2 of embryonic Japanese medaka was assessed at 120 and 144 hpf 
following an exposure to EE2 alone, HPβCD alone, and a combination of EE2 + HPβCD. 
At 120 hpf, a mean MO2 of 55.85 pmol/min was observed in the control embryos. Embryos 
exposed to 10 ng/L EE2, and 188 ng/L HPβCD alone, resulted in an MO2 of 49.05 
pmol/min and 65.87 pmol/min, respectively, neither of which was significantly different 
from the control (P > 0.05) (Figure 17). Likewise, embryos exposed to EE2 and HPβCD 
simultaneously, were not significantly different from the control (P > 0.05) (Figure 17). 
Mean MO2 at 144 hpf showed a similar result as 120 hpf, with no significant 
differences between the treatments and the controls (P > 0.05). Control embryos 
experienced a mean MO2 of 48.39 pmol/min, while embryos exposed to EE2 and HPβCD 
alone had a mean MO2 of 51.33 and 51.39 pmol/min respectively (Figure 18). Embryos 
exposed to EE2 in combination with HPβCD had a mean MO2 between 50.80 pmol/min 







Figure 17: Mean oxygen consumption (MO2) ± standard error per embryo of 120 hour post 
fertilization (hpf) Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) 
alone, hydroxypropyl-β-cyclodextrin (HPβCD) alone, or EE2 + HPβCD. Each treatment 
consists of six replicates containing 3 embryos per replicate. Significant difference from 







Figure 18: Mean oxygen consumption (MO2) ± standard error per embryo of 144 hour post 
fertilization (hpf) Japanese medaka (O. latipes) exposed to 17α-ethinylestradiol (EE2) 
alone, hydroxypropyl-β-cyclodextrin (HPβCD) alone, or EE2 + HPβCD. Each treatment 
consists of six replicates containing 3 embryos per replicate. Significant difference from 




Balance between energy input and output is critical to all organisms, including fish. 
In fish, many apical endpoints such as growth and survival can be impacted by an 
imbalance of energy (Houde and Schekter, 1983). These effects are often amplified during 
vulnerable life-stages. For example, spawning fish may experience limited food 
availability and high energy expenditure; embryonic fish have a finite energy supply stored 
as yolk. Perturbations in metabolic rate during sensitive life-stages, including 
embryogenesis may have significant impacts on fish development and growth (Woltering, 
1984; Koger et al., 2000). Energy consumption is commonly measured through oxygen 
consumption or heart rate. 
Recently, there has been a strong push in the field of aquatic toxicology to develop 
adverse outcome pathways (AOPs) (Ankley et al., 2010) In brief, AOPs are a method of 
linking molecular imitating events with associated biological responses. The goal of AOPs 
are to eventually aid in the prediction of toxic responses to a chemical. While the scope of 
this thesis was not to develop an alternative AOP of 17α-ethinylestradiol (EE2), the idea 
of linking EE2 activation of GPER to alterations in heart rate and oxygen consumption 
(MO2) was of interest. The general aim of this chapter was to determine if the observed 
changes in heart rate in Chapter 2 could be detected as changes in MO2. 
In this chapter, decreased MO2 was observed in 120 hpf Japanese medaka (Oryzias 
latipes) embryos exposed to 1 ng/L of EE2 (Figure 15). This datum point was the only 
correlated with the decrease in heart rate observed in Chapter 2. A trend of increasing MO2 
with increased EE2 concentration was detected at 144 hpf. Unlike the observations of 
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Folkerts et al., (2017), out results did not closely relate heart rate to MO2. Furthermore, 
MO2 was also not changed in the presence of EE2 and HPβCD. 
There is evidence that suggests that heart rate is not a reliable measure of 
metabolism in fish. In rainbow trout, alteration in stroke volume rather than heart rate is 
used to meet changing oxygen demands (Equation 6) (Stevens and Randall, 1967). Our 
data supports this argument and could explain the lack of relationship between the two 
endpoints. Additionally, embryonic teleost fish rely heavily on cutaneous gas exchange to 
meet metabolic demands (Pelster and Burggren, 1996; Wells and Pinder, 1996; Rombough 
and Ure, 2017). Since cutaneous gas exchange does not rely on the circulatory system for 
transport, cardiac output may also not be linked closely to metabolism at this life-stage. 
However, it has been demonstrated that metabolic demands and cardiac output do become 
more closely linked as development progresses (Pelster and Burggren, 1996). It would be 
valuable to determine if larval medaka express a tighter relationship between heart rate and 
metabolic rate upon exposure to EE2. 
The results presented in this chapter and supporting literature have indicated that 
changes in the heart rate of fish embryos do not tightly correlate to metabolism. However, 
it should be noted that estradiol (E2) has been linked to metabolism changes through insulin 
regulation in mammalian models (Sharma and Prossnitz, 2011). Insulin is a peptide 
hormone secreted by beta cells of the pancreas, and is responsible for glucose homeostasis. 
When blood glucose is high, insulin promotes the absorption of circulating glucose from 
the blood into the liver and fat where it is converted to glycogen or fats (Sonksen and 
Sonksen, 2000). During times of low blood sugar, insulin is down regulated and glucagon 
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is secreted by alpha cells. Glucagon stimulates the liver to release glucose through 
gluconeogenesis, effectively opposing the effects of insulin (Sonksen and Sonksen, 2000). 
In ovariectomized mice, which exhibited low levels of E2, the promotion of 
subcutaneous fat and inhibition of visceral fat was observed. Moreover, in GPER knockout 
mice, increased blood glucose, decreased insulin release, lower energy expenditure and 
increased weight have been observed; this indicates that may GPER have a role in 
metabolism via insulin secretion (Haas et al., 2009; Sharma et al., 2013; Davis et al., 2014). 
It is also speculated that glucose intolerance could be the result of elevated circulation of 
lipids and insulin resistance (Sharma et al., 2018). Furthermore, GPER knockout male mice 
were found to have an abnormal lipid profile with elevated levels of pro-inflammatory 
cytokines, and a decrease in the adipose-specific cytokine adiponectin (Sharma et al., 
2013). This highlights that GPER may have a role in regulating inflammation and the lipid 
profile of mice. 
EE2 has also been shown to decrease growth in fish. Zebrafish exposed to 25 ng/L 
EE2 were significantly shorter in length and lighter in body weight compared to the control 
(VANDENBELT et al., 2003). These growth effects are consistent with the interaction of 
E2 and GPER described in mice. 
Insulin in fish has been primarily studied in salmonid fish, and has been reported to 
be structurally similar to other vertebrate insulins (Navarro et al., 2014). However, a major 
difference between fish and mammalian insulin secretion response does exist, particularly 
in carnivorous fish. In fish, insulin secretion tends to respond more strongly to amino acids 
than glucose and varies between species (Navarro et al., 2014). This suggests that GPER 
may have a different metabolic role in fish than in mammals. The non-genomic role of 
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GPER in the metabolic effects of fish thus presents an interesting area of research and 
should be further investigated. 
While data from this chapter did not clearly demonstrate significant metabolic 
effects of EE2, there remains evidence that GPER plays an important role in metabolism 
through insulin regulation in mice. The lack of conclusive metabolic effects could be due 
to a lack of pancreatic development and function during the life stage tested, or biological 
differences between mice and Japanese medaka. Additionally, the subtlety of change may 
require a greater length of observation in order to tease out a metabolic effect. Given the 
known growth effects of EE2 and our increased understanding of GPER function, future 
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5. Chapter 5: Overall Conclusions 
The overall goal of this thesis was to identify a non-genomic mode of action for 
17αethinylestradiol (EE2) toxicity and the influence of hydroxypropyl-β-cyclodextrin 
(HPβCD). We approached this project from an environmental perspective, prioritizing low, 
environmentally relevant concentrations of EE2. In this study, reduced embryonic heart 
rate of Japanese medaka (Oryzias latipes) was the most prominent biomarker of EE2 
exposure. Supported by previous literature, it was demonstrated that the G protein-coupled 
estrogen receptor (GPER) was responsible for these changes in heart rate. This research is 
the first to demonstrate that GPER activation can reduce the embryonic heart rate of 
Japanese medaka at low concentrations. As GPER research has grown, it has become 
apparent that it may be responsible for many of the non-genomic effects of estrogen 
signaling. 
Use of embryonic Japanese medaka allowed for relatively high throughput study of 
these endpoints. Medaka exhibit high reproductive output and a clear chorion allows for 
clear observation of their hearts. Embryonic medaka blood is a vibrant red and very 
apparent during embryonic development. The length of medaka embryogenesis typically 
lasts 10 days, allowing for greater time of embryonic observation than in many other 
species of fish. For comparative purposes, embryogenesis of zebrafish (Danio rerio), 
another commonly studied fish for embryonic development and toxicity studies, typically 
lasts only four days (Romano et al., 2017). Depending on the endpoints investigated, 
developmental time can be an important factor in understanding toxicity (Bhandari et al., 
2015). In this thesis, the greater length of time was beneficial for the determination of 
137 
 
exposure effects as organogenesis progressed. However, variability was high at early and 
later stages of development highlighting an area of future research.  
Embryonic heart rate was investigated as the primary endpoint (biomarker) of 
chemical exposure in this thesis. Cardiac function, the driving force of the circulatory 
system, is responsible for delivering nutrients, removing waste, and gas exchange. The 
heart rate of vertebrates can be controlled by internal signaling as well as exposure to 
toxicants. We observed a decrease in heart rate following exposure to nominal 
concentrations as low as 0.1 ng/L EE2. We also determined through specific estrogen 
receptor agonists and antagonists that GPER was responsible for this effect. These results 
indicate that embryonic heart rate may be a good indicator of GPER activation as it is not 
influenced by ERα or ERβ activation. A knowledge gap that still remains following this 
research is an understanding of the downstream signaling of GPER at environmentally 
relevant concentrations of EE2. Given the many reported roles of GPER, determining this 
downstream signaling in fish is of value. Information from this future research may further 
elucidate the non-genomic responses of fish to EE2 exposure. 
The effects observed in Chapter 2 appeared to be transient in nature, with the heart 
rate of exposed embryos returning to control levels as well as increased variability as 
hatching approached. This led us to investigate the uptake of EE2 across the chorion. 
Uptake followed a sigmoidal pattern with permeability increasing with embryonic age. As 
expected, elimination followed an exponential decay pattern, but did not provide plausible 
evidence for the observed transient effect on heart rate. A major limitation of using 
radiolabeled isotopes in toxicological work is that only the absolute amount of 14C present 
in a sample is determined. This method does not take into consideration the potential 
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metabolism of the parent drug into inactive or metabolized forms. Future research into this 
aspect may help to explain the transient effects observed in this study and could further 
define when metabolism of EE2 becomes active in embryonic fish. 
Another goal of this thesis was to determine if a link existed between the observed 
effects on heart rate and changes in metabolic rate as measured by embryonic oxygen 
consumption. It was concluded that heart rate was not a good predictor of oxygen 
consumption in embryonic fish. This is supported by the fact that embryonic fish also rely 
on cutaneous gas exchange as well as cardiovascular circulation for respiration. In addition, 
fish are known to change stroke volume rather than heart rate to meet metabolic demands 
(Stevens and Randall, 1967; Rombough and Ure, 2017). Despite our results, there is strong 
evidence that GPER has an important metabolic role through control of insulin secretion 
and glucose tolerance in mammalian models (Haas et al., 2009; Davis et al., 2014). In fish, 
insulin is known to be more responsive to amino acids than glucose. This presents a rich 
area for future research from an aquatic toxicological perspective.  
Mixture toxicity has become an increasingly important area of aquatic toxicological 
research. Due to high variability of wastewater constituents, spatial and temporal factors 
often limit the applicability of whole effluent toxicity assessments. Using whole effluent 
toxicity data from a regulatory perspective can thus be challenging if the contribution of 
toxicity from each compound is not fully understood. Thus, investigating the interaction of 
multiple toxicants can provide valuable information about wastewater toxicity. A major 
goal of this thesis was to determine if the co-presence of HPβCD could alter the embryonic 
toxicity of EE2. We observed that the EE2-induced bradycardia was eliminated by the 
presence of HPβCD at 120 and 144 hours post fertilization (hpf). HPβCD is a large 
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hydrophilic compound that has the ability to include EE2. Given GPER is located 
intracellularly, it was hypothesized that HPβCD was impeding the interaction of EE2 and 
GPER. Uptake of EE2 across the chorion was not impeded by HPβCD, indicating that 
HPβCD may be able to cross the chorion pore canals. This presents an area of future 
research, where dechorionating the embryo following exposure to EE2 and HPβCD, may 
provide insight regarding the uptake of EE2 into tissues of the developing embryo. HPβCD 
is a unique compound from an aquatic toxicological perspective; we have demonstrated 
its’ ability to reduce guest toxicity, however in a wastewater treatment plant there is also 
the possibility that HPβCD will cause the mobilization from sediment of various toxicants. 
The solubility of compounds that that might otherwise have been adsorbed to sludge may 
significantly increase in the presence of HPβCD, thereby altering toxicant distribution and 
bioavailability in the environment. 
Overall, this thesis has contributed to the understanding of EE2 toxicity through a 
non-classical estrogen toxicity pathway. We have demonstrated that embryonic heart rate 
can be modified by GPER activation and not ERα or ERβ, highlighting a potential 
biomarker for non-genomic estrogen toxicity. More notably, GPER function could be a 
missing element in our current understanding of estrogen toxicity within aquatic 
ecosystems. Results from this thesis have also revealed the ability of HPβCD to alter EE2 
toxicity. This thesis has elucidated many avenues of future research that could greatly 
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Figure S19: Mean heart rate ± standard error (% change of control) of embryonic Japanese medaka (O. latipes) exposed to 
hydroxypropyl-β-cyclodextrin (HPβCD). The heart rate of each embryo was assessed once every 24 hours at 72 (A), 96 (B), 120 (C): 
144 (D), 168 (E), and (192) hours post fertilization (hpf). Significant differences between treatment and the carrier control (CC) (0.01% 












Figure S20: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, G-1, a G Protein-Coupled estrogen receptor (GPER) agonist alone, or EE2 + G-1 at 120 (A), 144 (B), 
168(C) and 192 (D) hours post fertilization (hpf). Each treatment consists of three replicates containing 7 embryos per replicate. 












Figure S21: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, Fulvestrant (ICI) (GPER agonist and ERα and ERβ antagonist) alone, or EE2 + ICI at 120 (A), 144 (B), 
and 168 (C) hours post fertilization (hpf). Each treatment consists of three replicates containing 7 embryos per replicate. Significant 












Figure S22: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, G-36 (GPER antagonist) alone, or EE2 + G-36 at 120 (A), 144 (B), 168 (C), 192 (D) hours post fertilization 
(hpf). Each treatment consists of three replicates containing 7 embryos per replicate. Significant differences from the control are 












Figure S23: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, PHTPP (ERβ antagonist) alone, or EE2 + PHTPP at 120 (A), 144 (B), 168 (C) hours post fertilization 
(hpf). Each treatment consists of three replicates containing 7 embryos per replicate. Significant differences from the control are 












Figure S24: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, ZK 164015 (ERα antagonist) alone, or EE2 + ZK 164015 at 120 (A), 144 (B), and 168 (C). Each treatment 













Figure S25: Mean heart rate ± SE (% difference from control) of embryonic Japanese medaka (O. latipes) exposed to 17α-
ethinylestradiol (EE2) alone, hydroxypropyl-β-cyclodextrin (HPβCD) alone, or EE2 + HPβCD at 120 (A), 144 (B), and 168 (C). Each 







Table S14: Uptake rangefinder of 14C-17α-ethinylestradiol (14C-EE2) in embryonic 
Japanese medaka (O. latipes). Mass of 14C-EE2 per embryo was determined from one 
replicate of 40 embryos. 
[14C-EE2] (ng/L) Mass of 14C-EE2 per Embryo (ng) Number of Replicates 
100 112.0 1 
1000 415.0 1 
10000 665.6 1 
